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Abstract
Mental health conditions affect various aspects of an individual’s quality of life (QOL).
Patients with anxiety and depression have a greater risk of having a negative perception
of QOL. The gap in practice was the lack of an assessment tool to measure QOL in
patients with mental health disorders. The purpose of this Doctor of Nursing Practice
project was to develop a clinical practice guideline (CPG) recommending the best
evidence-based measurement tool for QOL in patients with anxiety and/or depression.
The question that guided the CPG was: How should QOL be measured in patients with
anxiety and/or depression in the outpatient setting? The CPG could help clinicians ask
precise questions regarding the impact of anxiety and/or depression on patients’ QOL and
adjust the treatment plan to improve patient outcomes. The literature used to support the
CPG was graded, synthesized into recommendations, and evaluated by an expert panel
using the Appraisal of Guidelines Research and Evaluation (AGREE) II tool. The World
Health Organization Quality of Life Instrument-Short Form (WHOQOL-BREF)
questionnaire was recommended in the CPG as a reliable measurement tool to evaluate
QOL in patients with anxiety and/or depression. Peplau's interpersonal relations theory
was applied to emphasize the proper way for clinicians to interact with patients when
administering the WHOQOL-BREF questionnaire. The anticipated outcome of adoption
of the CPG is the efficient use of resources to improve patients’ QOL. The CPG is
intended to assist clinicians to evaluate and understand QOL perceptions to achieve the
social change of enhancing patient outcomes by improving treatment plans.
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Section 1: Nature of the Project
Introduction
In 2017, there were approximately 46.6 million adults aged 18 or older in the
United States with mental illness, this number signified 18.9% of all U.S. adults
(National Institute of Mental Health, 2019). According to Huo, Guo, Shenkman and
Muller (2018), as many as 25% of adults in the United States has some form of mental
health problem. Patients diagnosed with mental health disorders are known to have an
increased rate of chronic diseases including but not limited to cardiovascular diseases,
diabetes, obesity, asthma, epilepsy, and cancer (Huo et al., 2018). Mental health disorders
affect various aspects of the individual’s quality of life (QOL), such as their personal and
social relationships, employment, schooling, and physical abilities. It has been shown that
patients with other medical illnesses in addition to mental health disorders have
considerably greater impairment of their QOL (Huo et al., 2018).
Specifically, depression is a prevalent cause of disability worldwide (Choo,
Chew, Ho, & Ho, 2019). The World Health Organization (WHO) has projected that by
the year 2020, depression will be deemed the third leading cause of disability globally
(Sivertsen, Bjorklof, Engedal, Selbaek, & Helvik, 2015). Compared with other mental
disorders, depressed patients have reported lower QOL (Choo et al., 2019). Prior studies
observed that domestic life, work, and interpersonal activities were believed to be the
most altered functional domains in depression (Choo et al., 2019). People with depression
are more susceptible to having adverse outcomes such as low education level, marital
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disturbances, erratic employment, risk of developing secondary disorders, and premature
mortality because of suicide (Choo et al., 2019).
Similarly, anxiety disorders represent the most predominant classification of
mental health disorders (Muntingh, van der Feltz-Cornelis, van Marwijk, Spinhoven, &
van Balkom, 2016). Anxiety disorders can also have a negative effect on a person’s QOL
and are related to significant healthcare and productivity financial burden (Muntingh et
al., 2016). Anxiety and depression are among the most common mental health problems
across various ages of the lifespan (Hohls, König, Quirke & Hajek, 2019). Both disorders
have been linked to a substantial economic burden and adverse consequences including
increased risk for physical comorbidities (Hohls et al., 2019). For reasons previously
stated, it is vital to address these chronic mental health conditions to not only reduce
healthcare cost but to improve overall patient care and outcomes.
Problem Statement
QOL is defined as a person’s perception of their personal situation with regards to
their own physical, social, mental, and spiritual dimensions (Pinto, Fumincelli, Mazzoc,
Caldeira and Martins, 2017). QOL also refers to an individual’s well-being, satisfaction
in life, physical health, perceptions of social relationships, economic status, and
operational in activities of daily living and work. (Hofmann, Curtiss, Carpenter & Kind,
2017). This is normally evaluated through the subjective views of the person’s life
situations, perceptions of their mental and physical health, social and family
relationships, and functional ability at home and work (Hofmann et al., 2017).
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Effective treatments of mental health disorders such as depression can result in a
decline in depressive symptoms, improvement of psychosocial functioning, and increased
QOL (Hofmann et al., 2017). Nevertheless, the treatment effects on QOL have not
obtained as much attention as clinical measures of mental health disorders such as
depression or anxiety (Hofmann et al., 2017). It is likely due to regulatory agencies not
putting much value on QOL measures because they are not considered a primary
outcome measure during clinical trials (Hofmann et al., 2017). However, QOL measures
can affect treatments of mental health disorders by helping clinicians to carefully plan
and adjust treatments accordingly.
Connell, O'Cathain and Brazier (2014) mentioned that there have been changes in
the way mental health services are provided, changing from emphasis on treatment and
decreasing symptoms to a holistic approach taking into consideration of well-being,
recovery, social functioning, and QOL. For more people receiving mental health services
to recover and have a good QOL, there is a need for appropriate outcome measures to be
implemented (Connell et al., 2014). However, limited measures have been standardized
and regularly gathered across mental health services (Connell et al., 2014). QOL is
affected by the individual’s beliefs, values, well-being, and life experiences. Because
patients with mental health disorders have a greater risk of having a negative perception
of QOL, it is essential to identify the best approach to measure QOL in patients with
mental health disorders, specifically anxiety and/or depression. Clinicians can adopt this
approach to measure QOL in patients with anxiety and/or depression to better plan and
manage their treatments.
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Purpose Statement
The purpose of this Doctor of Nursing Practice (DNP) project was to develop a
clinical practice guideline (CPG) that provides recommendation on how to measure QOL
in patients with anxiety and/or depression. After review of the literature, I developed a
CPG identifying the most appropriate way to measure QOL and recommended it for use
in clinical practice, specifically with patients diagnosed with anxiety and/or depression in
the outpatient setting. Clinicians working with patients suffering from anxiety and/or
depression can use this CPG to evaluate a patient’s QOL. Currently, there is no gold
standard for measuring QOL, especially in mental health patients (Katschnig, 2006).
Therefore, it was necessary to develop a CPG that can guide clinicians on how to
evaluate patients’ perceptions of QOL as it relates to their disease process to
appropriately manage their treatments. Upon further review of the literature, the most
recent sources of evidence that discussed a gold standard for measuring QOL in mental
health patients could not be located; hence, I used of the article by Katschnig (2006).
In developing the CPG, Peplau’s interpersonal relationship middle-range
descriptive theory was used to emphasize the significance of interpersonal relationships.
Peplau’s work on interpersonal relations has had a significant impact on the development
of contemporary nursing and psychiatric nursing (Adams, 2017). Before QOL can be
properly evaluated, it is imperative that interpersonal relations are established to
effectively understand patients’ perceptions while being cognizant of the evaluator’s own
behavior. Peplau’s theory was used to guide clinicians on the best approach to interact
with patients when evaluating their QOL.
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Nature of the Doctoral Project
The doctoral project necessitated an extensive and vigorous literature review to
identify the best tool to measure QOL in patients with anxiety and/or depression. I
analyzed and synthesized the evidence retrieved from the literature review for relevance,
high quality, reliability, and validity. Each item of evidence was translated and
scrutinized to identify the best method to measure QOL in patients with anxiety and/or
depression. Based on the findings from the literature review process, I developed a CPG
recommending the best approach to measure QOL in patients with anxiety and/or
depression. After a robust literature review, I identified the World Health Organization
Quality of Life Instrument-Short Form (WHOQOL-BREF) questionnaire as the best tool
for clinicians to use to measure QOL in patients with anxiety and/or depression seeking
care in the outpatient setting. Clinicians working in outpatient setting (i.e., primary care)
can use the guideline as a framework to measure QOL in the target population by asking
specific questions outlined in each domain of the WHOQOL-BREF questionnaire.
Significance
Because mental health illnesses account for many disabilities in the United States
and worldwide, it was imperative to address this issue using an evidence-based CPG for
proper management. Developing a CPG that identifies the best QOL measurement tool to
utilize in clinical practice was necessary. The guideline would show the best way to use
the identified tool to evaluate QOL in a specified population for a social impact in
healthcare. A CPG on the QOL measurement tool was necessary to help clinicians
evaluate and understand QOL perceptions among individuals with anxiety and/or
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depression disorders. This CPG could enhance patient outcomes and impact treatment
plans to decrease disability rates nationally and globally.
Prasad, Angothu, Mathews and Chaturvedi (2016) mentioned that depression is
one of the most common mental health disorders and is estimated to be the fourth leading
cause of disability worldwide. Depression is estimated to become the second leading
cause of disability worldwide by 2020 according to the WHO (World Federation for
Mental Health, 2012). It is therefore important to develop a CPG to address such
disorders. Effective use of this CPG in the outpatient setting could promote its adoption
in other clinical areas to enhance quality of care and reduce healthcare costs related to
anxiety and/or depression disorders. This project can promote positive social change
according to Walden University’s mission by improving mental health and encouraging
people, organizations, and society to adopt a new best practice for a positive future.
Summary
Pinto et al. (2017) explained QOL as an individual’s perception of their personal
situation regarding their own physical, social, mental, and spiritual dimensions. Anxiety
and/or depression can have a negative impact on the QOL of individuals. Therefore,
incorporating this CPG into clinical practice can result in changes in care delivery as well
as making this CPG the gold standard for measuring QOL in patients with anxiety and/or
depression, especially because there is currently none available to clinicians. Effective
use of this CPG can enhance clinicians’ overall understanding about the impact of
anxiety and/or depression on patients’ QOL. Knowledge regarding this impact can help
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clinicians to either amend or enhance treatment plans to meet patient needs and improve
their overall QOL.
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Section 2: Background and Context
Introduction
In the CPG development, it was important to add concepts, models, and theories
to support the information presented in the guideline. Doing so adds quality and strength
to the information suggested in the CPG and promotes its use in practice. This section
focuses on the theory that clinicians can use when interacting with patients. The theory
can be applied when clinicians are asking questions and implementing the interventions
outlined in the CPG. The theory also explains specific behaviors that must be illustrated
when clinicians interact with patients. In this section, I also provide a brief overview
regarding the background information on the context and the theory applied in the CPG.
Additionally, the relevance of the CPG to nursing practice demonstrated in this section,
highlighting the necessity for the CPG development.
Theory
I used Peplau’s theory to guide the development of this CPG. Peplau's theory
focused on psychodynamic nursing to help nurses understand their own and others’
behaviors while applying principles of human relations to the problems that arise at
various experience levels (Adams, 2017). Peplau defined nursing “as an interpersonal,
therapeutic process that takes place when professionals, specifically educated to be
nurses, engage in therapeutic relationships with people who are in need of health
services” (Hagerty, Samuels, Norcini-Pala & Gigliotti, 2017, p. 162-163). Forming an
effective interpersonal relationship with patients is vital to positive health outcomes.
According to Peplau’s theory, the nurse-patient relationship must undergo three various
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phases for it to be successful. These phases are (a) orientation, (b) working, and (c)
termination (Hagerty et al., 2017).
Though there are three phases in Peplau’s theory, I used only the orientation and
working phases in this CPG. In the orientation phase of the theory, the nurse meets and
greets the patient who is seeking assistance with a perceived health problem (Adams,
2017). This phase permits nurses to meet patients to attain valuable information about
them as individuals (Hagerty et al., 2017). In the orientation phase, nurses must adopt the
role of a stranger but show respect and courtesy when interacting with the patient
(Hagerty et al., 2017). The working phase requires nurses to spend significant amount of
time interacting with the patient, conducting assessments to use in the patient education
and interdisciplinary meetings on patients’ care plans (Hagerty et al., 2017). During the
working phase, the roles of nurses are more recognizable to patients and they begin to
acknowledge nurses as health educators, resource personnel, counselors, and care
providers (Hagerty et al., 2017).
This CPG recommended that clinicians apply the two phases of Peplau’s theory as
guidance when asking patients questions outlined in the WHOQOL-BREF questionnaire.
For instance, in the orientation phase of Peplau’s theory, nurses are urged to show respect
and courtesy when interacting with patients (Hagerty et al., 2017). Likewise, when
clinicians are asking questions pertaining to the various domains on the WHOQOLBREF questionnaire, they are advised to do so in a respectful and courteous manner to
acquire helpful information. The working phase of Peplau’s theory is where time is spent
to conduct assessments to influence patients’ care (Hagerty et al., 2017). Clinicians are
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encouraged to apply the working phase of Peplau’s theory when conducting QOL
assessment of patients with anxiety and/or depression using the WHOQOL-BREF
questionnaire. Because the working phase demands extensive time to perform various
tasks , the CPG recommends clinicians to allocate sufficient time with patients when
eliciting the WHOQOL-BREF questionnaire to avoid rushing the assessment phase
because this can lead to skewed or unreliable responses. Employing the working phase of
Peplau’s theory can provide an opportunity to strengthen the clinician-patient
interpersonal relationship as well as obtain valuable responses to better understand the
impact of depression and/or anxiety on patients’ QOL.
Peplau’s theory contributed substantially to the formation of psychiatric/mental
health nursing as a clinical specialty (Adams, 2017). Psychiatric nursing has had an
important role the field of nursing and has served as the model for the whole
advancement of clinical nursing in the United States (Adams, 2017). Because the CPG
focused on psychiatric nursing, Peplau’s theory was quite applicable to help clinicians
understand their own as well as their patients’ behavior and apply principles of human
relations for a successful clinician-patient relationship.
Clinicians must incorporate strong interpersonal relations skills when interacting
with patients with depression and/or anxiety because ineffective coping mechanisms by
patients tend to result in negative feelings of self. However, with therapeutic
interpersonal skills, relationships between health care professionals and patients lead to
improved patient satisfaction, treatment adherence, improved QOL, and reduced levels of
anxiety and depression (Kornhaber, Walsh, Duff & Walker, 2016). Using interpersonal
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relations skills as illustrated in the orientation and working phases of Peplau’s theory can
help clinicians develop effective approaches for asking the questions on the WHOQOLBREF questionnaires, which may yield valuable responses to influence care.
Peplau’s theory was clearly demonstrated in a study conducted by Evans,
Deutsch, Drake, and Bullock (2017), which examined the nurse-patient relationship
settings through telephone encounters with underserved women at high risk for
depression residing in rural settings. From this study, researchers discovered that the
phases of Peplau’s theory were evident in their interactions and offered a robust platform
from which to validate and develop nursing interventions designed to improve mental
health (Evans et al., 2017).
For instance, during the orientation phase of Peplau’s theory in the study, the
nurse’s initial contact with the patient consisted of the nurse asking about the woman’s
smoking behaviors, and the nurse was able to align her own goals with that of the patients
(Evans et al., 2017). Additionally, the nurse evaluated the patients’ risks, resources,
challenges, and the related factors that could disturb the interaction (Evans et al., 2017).
The participants responded positively, which reflected their wish to participate in the
study as well as to share details about their lives (Evans et al., 2017). Likewise, in the
CPG, if clinicians apply the specified domains of Peplau’s theory such as the orientation
and the working phases, they will be able to seamlessly apply principles of human
relations to strengthen the clinician-patient relationship. Doing so can allow clinicians to
effectively deliver the WHOQOL-BREF assessment and gain valuable responses from
patients to better understand their QOL and modify treatment plans accordingly.
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Relevance to Nursing Practice
The aim of the CPG was to provide a method to translate evidence into nursing
practice to improve patient outcomes. Because anxiety and depression have such a
significant impact on the lives of affected individuals, it is imperative to address this
public health problem to increase patients’ QOL and decrease the financial healthcare
burden. Nursing professionals caring for individuals with anxiety and/or depression can
use this CPG as a method to evaluate the impact of patients’ conditions on their QOL.
Based on the information gathered from the CPG, nurses can collaborate with providers
to either initiate or amend specific treatments to address patients’ needs.
Advanced practice nurses can use this CPG to assess the targeted populations’
QOL to generate effective treatments to meet patients’ needs. For instance, if a nurse
practitioner (NP) use this CPG to assess that anxiety or depression has negatively
affected a patient’s social relationships, the NP can refer the patient to the Anxiety and
Depression Association of America website to search for a support group near the patient,
in addition to prescribing either an antidepressant or cognitive behavioral therapy to
improve the patient’s QOL. However, if the NP does not specifically inquire about the
patient’s social relationships based on the recommendations of this CPG, the nurse may
not know the impact of the patient’s anxiety or depression on the patient’s social life in
order to provide additional resources to enhance the patient’s mental health.
Local Background and Context
To inquire of patients, a series of questionnaires focusing on each domain of the
WHOQOL-BREF can be used to gather information about how anxiety and/or depression
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have affected the patient’s QOL, which will aid clinicians in making effective clinical
decisions. For instance, in the WHOQOL-BREF domain on physical health, questions
pertaining to the following areas of the patient’s physical health will be asked: activities
of daily living, dependence on medicinal substances and medical aids, energy and
fatigue, mobility, pain and discomfort, sleep and rest, and work capacity (WHO, 1996).
In the psychosocial domain, questions regarding the following are asked: bodily image
and appearance, negative feelings, positive feelings, self-esteem,
spirituality/religion/personal beliefs, thinking, learning, memory, and concentration
(WHO, 1996).
Questions pertaining to social relationships focus on areas such as personal
relationships, social support, and sexual activity (WHO, 1996). Lastly, questions centered
on the patient’s environment are concentrated on financial resources, freedom, physical
safety and security, health and social care such as accessibility and quality, home
environment, opportunities for acquiring new information and skills, participation in and
opportunities for recreation/leisure activities, physical environment
(pollution/noise/traffic/climate), and transport (WHO, 1996). The guideline was intended
to equip healthcare providers with accurate evidence and knowledge required to make
informed clinical decisions and deliver safe, effective care to patients suffering from
anxiety and/or depression. Each piece of evidence used to guide the development of this
CPG was evaluated based on the Appraisal of Guidelines Research and Evaluation
(AGREE) II criteria checklist to add quality and strength.
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In a local context, there was a gap in practice observed in a primary care setting of
a community medical center that treated patients with anxiety and/or depression. The
standard practice of this local organization was for nurses to conduct monthly phone calls
to patients with mental health disorders such as depression and/or anxiety and administer
the Generalized Anxiety Disorder seven-item (GAD-7) and Patient Health Questionnaire
nine depression scale (PHQ-9) assessment to evaluate treatment response in relation to
antidepressants. The gap in practice was that QOL was not measured, and as a result,
clinicians often encountered cases in which patients would have low scores on their
GAD-7 and/or PHQ-9 but verbalized disturbances in various aspects of their life affecting
their QOL. This gap was the reason for the development of the CPG: to help clinicians
measure QOL and understand the impact of depression and/or anxiety on patients’ QOL
to enhance or change treatment plans.
Role of the Doctor of Nursing Practice Student
As a DNP student, it was imperative to be able to translate the findings of
literature into clinical practice to improve patient outcomes. In developing the CPG to
measure QOL of patients battling anxiety and/or depression in the outpatient setting, a
series of steps were followed to reach success. First, it was important to ensure that there
was a need for development of this CPG. Based on evidence, there was not a gold
standard for measuring QOL in mental health patients (Katschnig, 2006). Therefore, the
role of the DNP student was to create a CPG recommending the best way to measure
QOL in patients with anxiety and/or depression, and perhaps, make the CPG a gold
standard.
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Since the CPG focused on patients with anxiety and/or depression, future
developments of CPG can target other common mental health disorders such as
schizophrenia, bipolar disorder, post-traumatic stress disorder or substance use disorders
seen in the outpatient setting. Due to lack of adequate assessment of QOL of mental
health patients, it was prudent to address this gap to ensure clinicians treating patients
with anxiety and/or depression have a reliable resource to utilize as guidance in their
clinical decision making.
Second, to enhance usability and applicability in practice, evidence used to
support the CPG was analyzed for accuracy, current and of highest level. Each piece of
evidence used in the CPG was evaluated for quality and strength. For instance, a
literature appraisal tool such as Grading of Recommendations, Assessment, Development
and Evaluations (GRADE) methodology was used to appraise each article.
Last, to ensure a high-quality CPG was developed, the AGREE II tool checklist
was used as a guide in the guideline development to ensure transparency and
completeness of the CPG. The AGREE II checklist has a structure of six quality areas
and its 23 key items that provides a systematic and reasonable method for reporting
critical information (AGREE, n.d.). The AGREE II criteria checklist is reliable and valid,
therefore using this tool as a framework and guidance in developing this CPG will add
quality in the hopes of making it the gold standard for measuring QOL in mental health
patients.
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Role of the Project Team
In completion of this doctoral project, I worked with individuals from various
healthcare backgrounds who served as my project team. Walden University assigned
faculty members which included one committee chair and a committee member who
served as mentors and reviewers of my project. Additionally, four external experts (one
Internal Medicine Physician, a Primary Care Clinical Psychologist, a Doctor of Public
Health who oversees social workers and programs for the aging adults with disabilities,
with larger population suffering from anxiety and/or depression, and a DNP who is an
educator as well as a floor nurse) with experience in anxiety and/or depression were
considered to assess the developed guideline for relevance using the AGREE II checklist.
The team members had opportunities to share their knowledge and contextual
insight relative to the doctoral project. The team members received information regarding
the project purpose, goals as well as the timeline to review and provide feedback. Prior to
the final approval of the project, my project team had several opportunities to review the
information and evidence presented in the CPG and offered substantial feedback.
Revisions were made based on the feedback received from the project team. My project
team were also informed on the status of the project when submissions were made to the
Walden University’s doctoral research site.
Summary
The development of a CPG starts with first identifying reasons for why the
guideline is needed to address a gap in practice. Identifying a specific theory to guide the
development of the guideline adds quality and promotes the likelihood of its application
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in clinical practice. The guideline has relevance to nursing practice since it offered
recommendations for nursing profession as well as other discipline to use to enhance
patient outcomes. It is vital to apply quality evidence when developing a CPG to enhance
usability and applicability in practice. The incorporation of a team approach in
developing this guideline added rigor which can promote clinical application to enhance
outcomes in patients suffering from anxiety and/or depression.
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Section 3: Collection and Analysis of Evidence
Introduction
High-quality, evidence-informed CPG provide a way to bridge the gap between
policy, best practice, local contexts, and the choices of patients (Kredo et al., 2016). For
decades, clinical guidelines have been supported as vital components of quality medical
practice (Kredo et al., 2016). The Institute of Medicine (IOM) defined clinical guidelines
as statements that consist of recommendations aimed to enhance patient care that are
informed by systematic review of research as well as assessment of both the benefits and
risks of alternative care (Kredo et al., 2016). The IOM statements regarding CPG align
with the objectives of the CPG in this project. The purpose of the CPG was to help
clinicians make informed clinical decisions regarding the proper care of patients with
anxiety and/or depression to enhance patient care using evidence-based
recommendations. To accomplish this, the strength of the evidence supporting the
recommendations of the CPG underwent critical appraisal to ensure relevance and
transparency.
Practice-Focused Question
The question used to guide the development of the CPG was:
PFQ: How should QOL be measured in patients with anxiety and/or depression in
the outpatient setting?
The population was patients diagnosed with anxiety and/or depression who sought care in
the outpatient setting, such as primary care. The intervention was a development of a
CPG to assist clinicians in asking specific questions pertinent to the mental health
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disorder (i.e., anxiety and/or depression) and its impact on various domains (physical
health, social relationships, psychosocial situation, and environment) of patients’ QOL.
The expected outcome was the promotion of efficient use of resources such as the CPG to
improve outcomes and QOL. The aim of the DNP project was to develop a CPG
recommending a QOL measurement tool to evaluate QOL of patients with anxiety and/or
depression in the outpatient setting. The recommendations made in the guideline are
intended to enhance patient care that are influenced by systematic review of evidence
translated into practice to improve outcomes.
According to Kilbourne et al. (2018) “while adequate structure measures create
the necessary infrastructure for reporting on processes and outcomes and conducting
improvement activities, they do not provide sufficient detail as to whether quality
services are actually being delivered as intended nor if the outcomes obtained are
acceptable” (p. 31). Preferably, process measures can fill this gap by assessing whether
evidence‐based practices are in fact being employed to yield the necessary outcome
(Kilbourne et al., 2018). These measures usually entail operationalizing clinical
guidelines into explicitly well-defined denominators and numerators and applying
information that can be dependably acquired from credible sources (Kilbourne et al.,
2018). Application of a CPG recommending the best way to measure QOL such as
focusing on what, why, who and how to measure QOL in the target population can help
clinicians make informed decisions regarding treatment plans to enhance outcomes.
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Sources of Evidence
There has been an increasing need for economic evaluation of mental health
services requiring healthcare professionals to assess how a specific intervention or
outcome measure impacts various domains of QOL important to mental health patients
(Connell et al., 2014). Therefore, the development of a CPG on the best way to measure
QOL can help clinicians to evaluate QOL perceptions in patients with anxiety and/or
depression. The CPG can be recommended as a standardized outcome measure of QOL
in patients with anxiety and/or depression. The sources of evidence used to support the
CPG were graded, synthesized, and structurally evaluated for usability and applicability
in practice.
To obtain data and resources required to complete this DNP project, Walden
University’s online library served as a platform to access various scholarly databases.
Through the Walden online library, I conducted a computerized search of the MEDLINE,
PubMed, and CINAHL databases to identify the most appropriate peer review literatures.
Additionally, I conducted a review of journals, research articles, books and prior
dissertations or theses that discussed the research question.
I performed an advanced search using keywords such as quality of life, mental
health disorders, psychiatric disorders, measuring quality of life, quality of life
measurement tools, perception of quality of life, depression, and anxiety. I used Boolean
phrase words such as AND OR to narrow the search. Additionally, each article relevant
to the research question was appraised, graded, and rated based on the level of evidence.
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The goal was to select research articles with the highest level of evidence to add quality
to the CPG. Each selected article was graded using the GRADE methodology.
I completed literature searches using MEDLINE, PubMed and CINAHL with the
most recent search. Articles were included for review if they met the following criteria:
(a) published not prior to 2006, (b) related to anxiety and/or depression, (c) related to
QOL, (d) discussed QOL measurement tools, and (e) published in English. Articles were
excluded for review if they offered subjective data (such as opinions) and were published
in a language other than English. The following were the keyword combinations
performed with each of the databases: (a) quality of life measurement tools AND mental
health disorders OR mental health illness OR psychiatric disorders, (b) measuring
quality of life AND mental health or mental illness or mental disorders AND depression
and anxiety, and (c) WHOQOL-BREF AND mental disorders AND primary care or
primary health care or primary healthcare.
The intended population was adult patients, all genders, ages 18 years and older,
seeking care in the outpatient setting. Inclusive criteria included patients diagnosed with
either anxiety and/or depression or both and taking either an antidepressant or prescribed
psychotherapy as first line treatments. The severity of patients’ condition must have been
mild to severe (such as GAD7 and/or PHQ9 scores greater than four) and able to be cared
for in an outpatient setting such as primary care. Patients with other medical conditions in
addition to their diagnoses of anxiety, depression, or both who were competent to make
decisions for their own healthcare were part of the inclusion criteria.
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Analysis and Synthesis
The aim for the DNP project was to develop a CPG recommending the best way
to measure QOL in patients diagnosed with anxiety and/or depression for application in
practice. I conducted a systematic review of the literature to examine various mental
health QOL measurement tools used previously for their relevance in clinical practice.
From this analysis of the literature, I developed a CPG recommending the best
measurement tool to utilize in assessing QOL in patients with anxiety and/or depression.
I critically appraised and rated each piece of evidence selected from the literature
search using the GRADE method. GRADE methodology applies a cohesive and
organized approach to determine the strength and direction of recommendations (Cabrera
& Pardo, 2019). GRADE is presently deemed as the best approach to create valid and
transparent recommendations due to its rigorous appraisal of (a) bias in the available
evidence, (b) the extent and solidity of the effects, (c) the presence of baffling factors,
and (d) discrepancies or other quality issues (Cabrera & Pardo, 2019). The GRADE
system helps to evaluate and rate the quality of a body of evidence as high, moderate,
low, or very low, and then categorizes the strength of recommendations as either strong
or weak (Kong et al., 2015). Rating each piece of evidence using the GRADE system
helped me to organize the quality of evidence at one of four levels (high, moderate, low,
and very low) based on five downgrade factors including limitations, inconsistency,
indirectness, imprecision, and publication bias (Kong et al., 2015).
Using the GRADE system, evidence graded as ‘‘High’’ meant there was strong
confidence that the genuine result lies closely to that of the projected outcome (Kong et
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al., 2015). Evidence that rated as ‘‘Moderate’’ implied that there was moderate
confidence in the projected outcome and the actual outcome is possibly close to the
estimated effect, but there was a likelihood that it was considerably different (Kong et al.,
2015). Evidence rated as ‘‘Low’’ indicated that there was limited confidence in the
estimated effect and that the true outcome might be significantly different from the
estimated effect (Kong et al., 2015). Last, evidence rated as ‘‘Very low’’ suggested that
there was very little confidence in the predicted outcome and that the real outcome
possibly would be noticeably different from the predicted outcome (Kong et al., 2015).
I used the GRADE methodology to rate each piece of evidence and assigned the
level of strength for each. Once each piece of evidence was graded, I synthesized it into
an evidence table for the purpose of managing the evidence (see Appendix A). From
there, I developed the guideline. Once the recommendations were written with the
supporting evidence, they were reviewed by an expert panel who used the AGREE II
checklist to evaluate the recommendations.
The AGREE II is a valuable tool that provides a framework for DNP to utilize as
a guide for developing CPGs. The AGREE II was published in 2003 by a group of
guideline developers to provide framework on evaluating the quality of guidelines
(AGREE, 2017). I chose this tool to guide the development of this CPG. Once the CPG
was developed, the AGREE II was used to assess the quality of the guideline. The
AGREE II is not only valid but is a reliable tool comprising 23 key items that are
arranged in six domains (AGREE, 2017). These six domains consist of scope and
purpose (Domain 1); stakeholder involvement (Domain 2); rigor of development
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(Domain 3); clarity of presentation (Domain 4); applicability (Domain 5); and editorial
independence (Domain 6; AGREE, 2017).
The steps involved in developing the CPG consisted of first evaluating and
grading each piece of literature. After each piece of literature was graded, I developed the
CPG focusing on six areas: (a) the scope and purpose section (which conveyed the
guideline objectives, the clinical question, and the patient population to whom the
guideline was meant to apply); (b) stakeholder involvement (which depicted the views of
intended users); (c) rigor of development (which described the approach used to gather
and synthesize evidence); (d) clarity of presentation (which dealt with format, structure,
and language of the guideline); (e) applicability (which explained facilitators and barriers
of implementation and cost of implementation); and (f) editorial dependence (which
defined the development of recommendations not being overly biased with opposing
interests).
The written recommendations were reviewed and graded by a local expert panel
who used the AGREE II instrument to validate its contents. After the expert panel scored
the guideline based on the AGREE II instrument, I revised the guideline based on the
feedback received from them. I disseminated the revised guideline to the same local
experts to validate content and appropriateness using the AGREE II instrument until a
higher score was attained without further revisions. After the development of the CPG,
the expert panel reviewed the content, methodology, and evidence used to support the
CPG using the AGREE II checklist.
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Because the DNP project was to develop a CPG, there were no human study
participants in the guideline development. As part of an ethical consideration, I obtained
Institutional Review Board (IRB) approval prior to the development of the CPG
(approval # 04-24-20-0980598). Prior to receipt of the IRB approval, I completed a
specified form that was accepted by the IRB before I developed the guideline. This
specified form consisted of information regarding the DNP project details, method of
data collection, partner roles, and partner organization. A local primary care organization
was selected as the partner site that can use the recommendations made in the guideline.
Summary
Developing a CPG that enhances care delivery and patient outcomes must be
strategically formulated with good context based on the highest level of evidence to
support it. To ensure the CPG was supported with the highest level of evidence, each
piece of literature was retrieved from a scholarly database and critically appraised using
programs such as the GRADE methodology to ensure relevance, reliability, and validity.
Subsequently, the final CPG underwent review using the AGREE II instrument to
evaluate whether it met the criteria outlined under each domain of the AGREE II
checklist to ensure completeness and transparency. After appraising the CPG using the
AGREE II, revisions were made accordingly.
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Section 4: Findings and Recommendations
Introduction
Anxiety and depression have a significant impact on patients’ QOL, contributing
to higher morbidity rates. In clinical practice, guidelines are formulated to offer clinicians
the evidence and knowledge required to provide efficient, high-quality, and safe care to
populations with certain clinical conditions. This section addresses the evidence used to
support the recommendations of the guideline focusing on the strengths and limitations of
each piece of literature. It also provides an overall discussion on how the guideline was
developed using the GRADE methodology to analyze the evidence supporting the
recommendations and the AGREE II instrument used to evaluate the guideline once it
was developed. In addition, this section includes an in-depth discussion of the
WHOQOL-BREF questionnaire as the recommended tool to measure QOL in individuals
with anxiety and/or depression.
In this DNP project I aimed to answer the following practice focused question:
PFQ: How should QOL be measured in patients with anxiety and/or depression in
the outpatient setting?
The purpose of the CPG was to help clinicians measure QOL in patients suffering from
anxiety and/or depression disorders to make informed decisions regarding their care and
enhance outcomes using evidence-based recommendations. The CPG can offer guidance
on how to evaluate patients’ perceptions of QOL based on various domains such as
physical health, social relationships, psychological health, and environment in order to
make necessary adjustments in their care to improve outcomes as well as their QOL.
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Findings and Implications
The gap in practice was that there was no guideline focused on a standardized tool
to measure QOL for individuals with anxiety and/or depression. Therefore, I conducted a
literature review to develop a guideline identifying the best tool to measure QOL in
patients diagnosed with anxiety and/or depression. To create the CPG, I reviewed and
analyzed various literature for relevance to the health question.
Upon review of the literature, I determined there was no standardized QOL
measurement tool for clinicians to use to assess QOL in patients with anxiety and/or
depression. Current assessment of the impact of anxiety and/or depression on the
patients’ health is based on the evaluation of PHQ-9 and 7-item GAD-7. These two
assessments tools are among the best validated and most frequently used depression and
anxiety measures, respectively (Kroenke et al., 2016). They have been applied in
hundreds of research studies, integrated into various CPGs, and implemented by a range
of medical and mental health care practice settings (Kroenke et al., 2016). Despite the
validity of the PHQ9 and GAD7 assessment tool, they do not directly evaluate domains
of QOL as illustrated on the WHOQOL-BREF questionnaire. The use of the PHQ9 and
GAD7 in patients with anxiety and/or depression in the outpatient setting would continue
to remain as options for assessing the impact of the disease on the individual’s health.
However, to obtain detailed understanding on patients’ QOL, the PHQ9 and GAD7 may
not offer clinicians adequate insights on patients’ QOL due to their specificity on
measuring depression and anxiety.
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Evaluating the quality of evidence is a relatively new practice that is aimed at
determining the credibility and trustworthiness of the evidence across studies as it relates
to a research question (Movsisyan, Dennis, Rehfuess, Grant & Montgomery, 2018). The
body of evidence supporting the recommendations in the CPG were assessed for
strengths and limitations. Kilbourne et al. (2018) presented a framework that supports
quality measurement as a tool for enhancing quality of mental health care. Kilbourne et
al. explained key barriers to this effort such as absence of standardized information
technology-based data sources, inadequate scientific evidence for mental health quality
measures, absence of provider training and support, as well as cultural barriers to
integrate mental health care in general health situations. Kilbourne et al. also highlighted
several improvements that are in progress globally to relieve these barriers.
Slade et al. (2006) conducted a randomized control study to assess the efficacy of
standardized outcome assessment in 160 adult mental health patients and paired staff.
The intervention group (n = 101) completed a monthly postal questionnaire to evaluate
their needs, QOL, severity of their mental health problems and therapeutic alliance and
received three monthly feedbacks. The control group (n = 59) received usual treatment
(Slade et al., 2006).
Results showed that intervention failed to enhance primary outcomes of patientrated unmet needs and of QOL (Slade et al., 2006). Other subjective secondary outcome
measures were also not enhanced, but the intervention decreased psychiatric inpatient
days, showing a net benefit analysis of the intervention as cost-effective (Slade et al.,
2006). Despite the interventions not enhancing primary and subjective secondary
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outcomes, it was cost-effective and showed that it is feasible to apply a meticulously
developed method to regular outcome assessment in mental health services (Slade et al.,
2006).
The study’s limitations consisted of the service use data acquired by patients’ selfreport which could have been unreliable (Slade et al., 2006). Another limitation of the
study was that neither patients nor staff were disguised to allocation status (Slade et al.,
2006). Researchers who conducted the follow-up interviews were partially masked and
conjectured allocation status accurately for 38% of staff and for 68% of patients (Slade et
al., 2006). Furthermore, within the control group, 46 (78%) of the 59 patients had a
member of their staff who also received an intervention-group patient, suggesting that
contamination was likely among the two groups (Slade et al., 2006). Lastly, the follow-up
period of 7 months may have been inadequate because more time was needed to capture
all the possible changes the interventions generated (Slade et al., 2006). When
considering the evidence by Slade et al. (2006), reviewers should be advised that the
focus was not on a specific tool to measure mental health outcomes but stressed the
feasibility of the implementation of a carefully developed technique to routinely evaluate
outcomes in mental health services.
Kilbourne et al. (2018) offered numerous recommendations for enhancing the
quality of mental health care. As part of their recommendations, Kilbourne et al.
suggested the routine measurement of mental health outcomes and incorporating this
evaluation within the whole culture of the treatment setting and health care system.
Primary care setting is considered one of the environments that adoption of mental health
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outcome measures can be used routinely to improve the quality of mental health services.
The evidence by Kilbourne et al. added quality to the CPG because they highlighted a
recommendation on the frequency of mental health outcome measurements. The
limitation on using this evidence was that the authors discussed the use of the
recommendations for the general mental health care sectors and not specifically patients
with anxiety and/or depression in the primary care setting.
Oliveira, Carvalho, and Esteves (2016) examined the psychometric properties of
the WHOQOL-BREF by analyzing its construct validity, predictive validity, and
reliability in a psychiatric sample. The results of the study added to a growing body of
research findings and provided support for the use of the WHOQOL-BREF for patients
with mental health conditions in both the inpatient and outpatient settings (Oliveira et al.,
2016). The broad body of research methodically developed with the WHOQOL-BREF,
reinforces the use of this questionnaire as a reliable and valid instrument to address QOL
(Oliveira et al., 2016). This study provided a confirmatory evidence of the
appropriateness of the WHOQOL-BREF with psychiatric inpatients and outpatients
(Oliveira et al., 2016).
Despite the strengths, there were limitations in this study. Some of the study
participants were inpatients in both short-term and long-term residential programs having
more limited daily activities, which may have affected the results, specifically, regarding
the environment domain of the WHOQOL-BREF (Oliveira et al., 2016). Additionally,
because the study used a cross-sectional approach, findings should be required to be
repeated applying a longitudinal research design to strengthen understanding the
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dimensionality of the WHOQOL-BREF in psychiatric samples as well as the analytical
capacity of its domains (Oliveira et al., 2016). The results of the study provided
implications and guidance for future research and clinical practice (Oliveira et al., 2016).
The results offered evidence to thoroughly examine the dimensional structure of the
WHOQOL-BREF across various subgroups, requiring more transparency on the
WHOQOL-BREF performance in psychiatric samples (Oliveira et al., 2016).
This study had importance because it was not restricted to participants with a
specific psychiatric diagnosis or partaking in a particular treatment milieu, emphasizing
that evaluating the QOL of individuals with mental health disorders receiving care for
different settings such as inpatient and outpatient facilities must be the core of research
and treatment goal (Oliveira et al., 2016). Furthermore, because enhancing these
individuals’ QOL has become a vital outcome measure concerning mental health services
evaluation, this may add to more understanding that the QOL of those attending various
psychiatric treatment modalities (such as hospital-based inpatient long-term and shortterm care, ambulatory services, or community-based facilities) could monitor possible
changes on the individuals’ QOL (Oliveira et al., 2016).
Tüzün, Aycan, and İlhan (2015) examined the effect of chronic disease on the
QOL and how QOL changed with comorbidity and socioeconomic status in individuals
who received care in the primary health care centers using the WHOQOL-BREF. The
results revealed that people with mental health disorders and diabetes-hypertension
comorbidity had the most negative impact on their QOL (Tüzün et al., 2015). Mental
disorders had the worst impact on the psychological and social relationships domains of
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the WHOQOL-BREF; depression and anxiety were recorded as the diseases with the
highest negative effect on QOL (Tüzün et al., 2015). The results suggested that providing
mental health services for primary health care patients with a mental disorders and
patients with physical chronic diseases is vital to increase their QOL (Tüzün et al., 2015).
Additionally, findings from this study illustrated that efforts to improve the QOL
of people with chronic disease cannot be successful without considering the social factors
of health (Tüzün et al., 2015). These findings support the use of WHOQO-BREF to
determine QOL in patients suffering from depression and/or anxiety in the primary care
setting. The self-report of the participants on the presence of chronic disease may have
been a limitation of this study (Tüzün et al., 2015). Nevertheless, it was essential to apply
an alternative source because the records of chronic diseases that was registered at
primary health centers were inadequate (Tüzün et al., 2015). The diseases reported were
categorized according to the International Classification of Diseases codes for evaluations
(Tüzün et al., 2015). Even though they may be of the similar group, various diseases can
impact QOL in different ways (Tüzün et al., 2015). Consequently, a comparison based on
the diagnoses would have been more illuminating for the researchers (Tüzün et al., 2015).
Dzevlan et al. (2019) investigated possible improvement of QOL in patients with
depression and/or anxiety disorder who utilized antidepressants in the study, and the
tolerability of the treatment administered as well as patients’ compliance during the
study. This was a clinical, multicenter, prospective, cohort study with 682 adult patients
with depression and/or anxiety disorder (Dzevlan et al., 2019). The Sleep Scale from the
Medical Outcomes Study (MOS Sleep Scale) was used to evaluate sleep quality and
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Quality of Life and Satisfaction Questionnaire (Q-LES-Q-SF) were used to assess life
enjoyment and satisfaction (Dzevlan et al., 2019).
The results indicated an increase in sleep quality with antidepressant therapy and
substantial enhancement in enjoyment and life satisfaction in all the three groups of
patients considered in the study (Dzevlan et al., 2019). These findings indicated that
improvement in QOL can be seen with antidepressant therapy (Dzevlan et al., 2019). The
results of the study may be limited because of the type of questionnaire utilized as a QOL
measurement (Dzevlan et al., 2019). Dzevlan et al. (2019) mentioned that all the
questionnaires were self-disclosures with a possible risk of misrepresentation or bias in
the responses (Dzevlan et al., 2019). The clinician-reported outcome assessments could
provide a better understanding into patients’ antidepressant therapy related QOL
(Dzevlan et al., 2019).
Another limitation was that researchers did not examine how engaged patients
were in treatment decisions or in the patient–physician relationship, that could further
clarify the results of patients’ compliance to therapy or treatment satisfaction (Dzevlan et
al., 2019). A limitation to bear in mind when considering this evidence is that a different
QOL measurement besides the WHOQOL-BREF was used to assess QOL perceptions.
Additionally, this evidence was used to provide an overview of specific timeframes of
when QOL measurements can be done in the clinical setting after starting antidepressant
therapy for depression and/or anxiety disorders.
Deane and Fain (2016) examined Peplau’s interpersonal relations theory as a
framework to help nursing students to comprehend holistic communication skills during
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their interactions with older adults. Application of Peplau’s theory could be utilized as a
framework in nursing education to structure classrooms, post-conferences, and skills
laboratory presentations on components of delivering holistic care and communication
(Deane & Fain, 2016). Though this evidence was geared towards nursing education, it
provided valuable information on ways to promote therapeutic nurse-patient relationship
using Peplau’s theory.
This evidence supported the interventions (i.e., behaviors and attitudes) that
clinicians need to demonstrate when asking patients questions on the WHOQOL-BREF
questionnaire to build effective clinician-patient relationship. When considering the CPG,
be advised that though Peplau’s interpersonal relations theory has been widely used in
patients with mental health disorders, a recent evidence discussing the application of the
three phases of the theory (orientation, working and termination) in patients with
depression and/or anxiety in the primary care setting, specifically, could not be found.
The literatures with applicability were graded using the GRADE methodology to
evaluate its strength and quality to support the recommendations within the guideline.
The GRADE methodology applies a cohesive and organized approach to determine the
strength and direction of recommendations (Cabrera & Pardo, 2019). The strength of
each piece of evidence was assigned a grading level of very low, low, moderate, and
high. Each piece of evidence was synthesized into an evidence table to manage the
evidence (Appendix A). The guideline was created using the graded evidence to support
the recommendations. Recommendations made under each heading of the CPG has its
corresponding evidence to support them.
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Once the evidences were graded and analyzed, the guideline was developed.
Recommendations were written with support from the evidence to illustrate relevance
and transparency. I used the AGREE II instrument to assess quality and ensured all
domains of the tool were addressed in the guideline. Afterwards, four experts who
consisted of an Internal Medicine Primary Care Physician, a Primary Care Clinical
Psychologist, a Doctor of Public Health and a DNP who still works as a part-time floor
nurse and a fulltime educator reviewed and evaluated the completed guideline using the
AGREE II instrument. The guideline and the AGREE II instrument were provided in an
electronic form to each of the four experts. The AGREE II instrument consist of a 23section appraisal evaluating six key aspects of a CPG development (AGREE, 2017). The
six domains of the tool focused on scope, stakeholder involvement, consistency, clarity,
applicability, and editorial independence (AGREE, 2017). Experts could rate each
domain with a score of one to seven with a seven being the maximum attainable score.
The experts scored each recommendation using the AGREE II tool. In the first
evaluation of the CPG by the expert panel there was not 100% agreement in terms of the
scores. The Doctor of Public Health and the DNP gave the guideline a score of seven out
of seven and graded “yes” for the overall guideline recommendation for use in practice.
The Primary Care Clinical Psychologist and the Primary Care Physician graded the
guideline six out of seven and marked it as “yes with modifications” for the overall
guideline recommendation for use in practice. The results of the first expert review are
presented in Table 1.
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Table 1
AGREE II Experts Overall Guideline Assessment Scores
Question 1: Rate the overall quality of this guideline.
Question 2: I will recommend this guideline for use
(Yes/No).
Rate

Yes/No

Appraiser 1

7

Appraiser 2
Appraiser 3

Total

Score

Yes

7

100%

7

Yes

7

100%

6

Yes, with

6

85%

6

85%

26

92%

Modifications
Appraiser 4

6

Yes, with
Modifications

Total

26

Note. Scoring the AGREE II ranges from 1 (lowest possible quality) through 7 (highest possible quality).
Since there were four appraisers, the maximum total score achievable was 28 and the minimum total score
possible was four. The total score percentage was achieved by combining each appraiser’s score and
dividing by the total possible points. Such as 26/28=.92; .92 x 100 = 92%

The revisions required as suggested by the two experts (primary care clinical
psychologist and the primary care physician) were to clarify the views and preferences of
target population; the health benefits, side effects, risks for formulating the
recommendations; and making the recommendations more specific. Once feedback was
received from the expert panel, I revised the guideline focusing on the areas suggested by
the two experts (primary care clinical psychologist and the primary care physician). After
the revisions were made, I sent it back in an electronic form to the two experts for a
second evaluation which resulted in a maximum score of seven without the need for
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additional revisions. The results of the second expert review are presented in Table 2.
Once there was no revision required from the experts, the CPG was completed (Appendix
B).
Table 2
AGREE II Experts Overall Guideline Assessment Scores
Question 1: Rate the overall quality of this guideline.
Question 2: I will recommend this guideline for use
(Yes/No).
Rate

Yes/No

Appraiser 3

7

Appraiser 4

7
Total

Total

Score

Yes

7

100%

Yes

7

100%

14

100%

14

Note. Scoring the AGREE II ranges from 1 (lowest possible quality) through 7 (highest possible quality).
Since there were two appraisers, the maximum total score achievable was 14 and the minimum total score
possible was two. The total score percentage was achieved by combining each appraiser’s score and
dividing by the total possible points. Such as 14/14=1; 1 x 100 = 100%

Recommendations
The IOM defined clinical guidelines as statements that consist of
recommendations aimed to enhance patient care and informed by systematic review of
research as well as assessment of both the benefits and risks of other alternative care
(Kredo et al., 2016). The IOM statements regarding CPG aligns with the objectives of
this CPG. This section describes the recommendations on the best way to measure QOL
in patients with anxiety and/or depression. Various aspects of the recommendations such
as a discussion of the WHOQOL-BREF tool, domains of the WHOQOL-BREF,
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reliability of the WHOQOL-BREF, scoring the WHOQOL-BREF and application of
Peplau’s theory when using the WHOQOL-BREF tool are considered in this section.
The importance of using the guideline is to help clinicians evaluate QOL in
individuals with anxiety and/or depression to adjust or enhance their treatment plans for
better outcomes. After review of the literature, the best tool recommended to use in the
guideline was the WHOQOL-BREF questionnaire to measure QOL. With the developed
CPG, a vital aspect is understanding what, when, how to use the WHOQOL-BREF tool
along with interventions guided by Peplau’s theory to measure QOL. These important
aspects of the WHOQOL-BREF questionnaire are presented in this section.
World Health Organization Quality of Life Instrument-Short Form Tool
The CPG outlines step by step process for measuring QOL in patients with
anxiety and/or depression disorders. To elicit this measurement, clinicians can follow the
CPG and inquire from patients the impact of their anxiety and/or depression on their
QOL in various domains of life. Patients’ QOL can then be evaluated using the
WHOQOL-BREF questionnaire which consists of different domains such as physical
health, psychological health, social relationships, and environment. The WHOQOLBREF is available in 19 various language versions (WHO, 1996). The WHOQOL-BREF
questionnaire contains questions relating to each domain of QOL (Feder et al., 2015). The
domains identified in the WHOQOL-BREF will be the areas of QOL that clinicians can
use to gather information from patients to appropriately plan their care. The WHOQOLBREF questionnaire was derived from the WHOQOL-100 which was also developed by
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the WHO. The expected outcome of the CPG is the promotion of efficient use of the CPG
to improve patient care.
Each domain on the WHOQOL-BREF has specific targeted questions that
clinicians would ask patients to obtain responses regarding their QOL. The application of
WHOQOL-BREF questionnaire added quality and strength to the CPG because it is a
reliable tool and has been used previously in several research to measure QOL. Oliveira,
Carvalho and Esteves (2016) mentioned that the WHOQOL-BREF was considered a
valid and reliable instrument for academic research, clinical evaluations, and crosscultural comparisons.
The WHOQOL-BREF has been extensively field-tested in numerous countries
and its psychometric properties have proven to be sufficient for its utilization in various
cultures and with a range of population groups such as young people, adults and the
elderly (Oliveira, Carvalho & Esteves, 2016). It has also been utilized in groups with
certain medical problems including patients with cancer, epilepsy, and mental disorders
such as depression, bipolar disorders, psychosis, schizophrenia, and alcohol abuse
(Oliveira et al., 2016). In a study conducted by González-Blanch et al. (2018), the
WHOQOL-BREF was used to assess four different QOL domains (physical health,
psychological health, social relationships, and environment) in primary care patients with
emotional disorders such as depression, anxiety and somatization. The use of the
WHOQOL-BREF in this study proved to be valid, reliable, and helped researchers
understand the relationships between common emotional disorders (such as anxiety
and/or depression) and the impact on their QOL.
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The CPG recommended that clinicians administer the WHOQOL-BREF
questionnaire with each adult patient (ages 18years and older) diagnosed with anxiety
and/or depression to obtain a baseline assessment score. Thereafter, periodic assessment
measurement using the WHOQOL-BREF is recommended to evaluate changes in their
QOL and to modify treatment plans accordingly. Patients who are competent are
appropriate to self-administer the WHOQOL-BREF after clinicians gives them
instructions (WHO, 1996). However, an interviewer-assisted or interview-administered
forms should be read out to patients in cases where the assessment is intervieweradministered (WHO, 1996).
Domains of WHOQOL-BREF. When determining the influence of anxiety
and/or depression on patient’s QOL, series of questionnaires focusing on each domain of
the WHOQOL-BREF are elicited to gather information for clinicians to make effective
clinical decisions. The WHOQOL-BREF questionnaire starts with two questions to
evaluate the patients’ overall QOL and their general health. The questions must appear in
the order in which they occur as illustrated below under “The WHOQOL-BREF
Questionnaire” (Appendix C and D).
The domain on physical health contains questions pertaining to the following
areas of the patient’s physical health; activities of daily living, dependence on medicinal
substances and medical aids, energy and fatigue, mobility, pain and discomfort, sleep and
rest, and work capacity (WHO, 1996). Subsequently, in the psychosocial domain,
questions regarding the following are asked; bodily image and appearance, negative
feelings, positive feelings, self-esteem, spirituality/religion/personal beliefs, thinking,
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learning, memory, and concentration (WHO, 1996). Questions pertaining to social
relationships are focused on areas such as personal relationships, social support, and
sexual activity (WHO, 1996). Lastly, questions centered on the person’s environment
explores financial resources, freedom, physical safety and security, health and social care
such as accessibility and quality, home environment, opportunities for acquiring new
information and skills, participation in and opportunities for recreation/leisure activities,
physical environment (pollution/noise/traffic/climate), and transport (WHO, 1996).
Reliability of WHOQOL-BREF tool. The WHOQOL-BREF assessment tool
was published in 1996 by the WHO with the identified instructions as previously stated
and has been used in its original form without changes since then. It has been widely used
in numerous research and has been found to be a valid and reliable tool to measure QOL.
The four QOL domain scores indicate an individual’s perception of QOL in each domain
(WHO, 1996). QOL domain scores are scaled in a positive direction, for instance, a
higher score represents a higher QOL (WHO, 1996). The WHOQOL-BREF assessment
can help clinicians to make judgments regarding the domains in which a patient is mostly
affected by their disease to make treatment decisions (WHO, 1996). Along with other
clinical measures, the WHOQOL-BREF will assist clinicians to assess changes in QOL
over the course of patients’ treatments (WHO, 1996).
The reliability of WHOQOL-BREF was examined in a literature review of a study
that observed its psychometric properties by also exploring its construct validity, as well
as predictive validity in a psychiatric study sample such as those with anxiety and/or
depression (Oliveira et al., 2016). Findings from this review supported the
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multidimensionality of the WHOQOL-BREF and demonstrated it to be suitable for
assessing QOL in psychiatric inpatients and outpatients (Oliveira et al., 2016).
Additionally, the WHOQOL-BREF showed that it was a valuable instrument to be
incorporated as part of the routine clinical evaluation, monitoring and an important
indicator of treatment outcome as well as research (Oliveira et al., 2016).
When clinicians are administering the WHOQOL-BREF questionnaire, they
would ask patients about their QOL by asking specific questions under each domain of
the WHOQOL-BREF questionnaire. For interview-assisted assessment, clinicians can
read out each question to patients, alongside the response options (WHO, 1996).
Clinicians would ask patients to choose the most appropriate answer after reading the
responses (WHO, 1996). Clinicians should inform patients that if they are unsure about
which response to provide for a specific question, the first response they think of is
frequently the best one (WHO, 1996). Clinicians should also remind patients of their
standards, hopes, pleasures and concerns and ask them to think about their life in the past
four weeks (WHO, 1996).
Scoring the WHOQOL-BREF. The WHOQOL-BREF questionnaire generates a
QOL profile of the individual taking the assessment (WHO, 1996). It is likely to obtain
four domain scores (WHO, 1996). Question one and two are examined separately since
question one asks about the person’s overall QOL and question two asks about overall
perception of their health (WHO, 1996). The four domain scores represent the person’s
perception of QOL in each domain (WHO, 1996). Domain scores are scaled in a positive
direction such as a higher score indicates greater sense of QOL (WHO, 1996). The mean
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score of items in each domain is utilized to determine the domain score which is then
multiplied by four to be comparable to the scores obtained on the WHOQOL-100 (WHO,
1996). Manual calculation of the scores are presented at the end of the questionnaire for
the interviewee to calculate the raw domain scores which is then transformed to a 4-20
score (WHO, 1996).
Application of Peplau’s Theory and the WHOQOL-BREF Tool. An essential
aspect of the CPG is the ability for clinicians to incorporate significant phases of Peplau's
interpersonal relations theory to establish effective relationships with patients. By
incorporating Peplau’s theory, clinicians can engage in therapeutic relationships with
patients diagnosed with anxiety and/or depressive disorders, which can assist them to
holistically care for patients as individuals in need of mental health services.
Additionally, as clinicians go through various phases of Peplau’s theory to build rapport
with patients, they can use effective communication skills to collect valuable information
from patients to understand their needs and the effects of their mental health disorders on
their QOL. Using such approach can reduce their anxiety and provide a conducive
environment during the clinician-patient interaction to attain a more reliable, unbiased
responses from patients to better measure their QOL. Application of Peplau’s theory can
help to establish interpersonal relations skills that clinicians need to effectively interact
with patients.
Contribution of the Doctoral Project Team
The doctoral project team who contributed their expertise to the project included
an internal medicine physician who works in a primary care clinic and as a hospitalist in a
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local hospital, a clinical psychologist who works in outpatient primary care setting, a
doctor of public health who oversees social workers and programs for the aging adults
with disabilities, with larger population suffering from anxiety and/or depression, and a
DNP who is an educator as well as a floor nurse in the emergency department. Each of
the team members had expertise working with patients diagnosed with anxiety and/or
depression.
Team members shared their knowledge regarding the health question considered
for the guideline and provided helpful feedback on various scholarly references with
relevance to the guideline development. After the completion of the guideline
development, each team member graded the guideline for its contents, relevance and
appropriateness using the AGREE II checklist. Though the CPG was not implemented at
a specific organization to assess its validity, the evaluation process it underwent using the
AGREE II instrument by the project team added strength and quality to the guideline.
The overall aim for the doctoral project was to develop a CPG recommending the best
way to measure QOL in patients with anxiety and/or depression, no actual
implementation was intended for the guideline.
Strengths and Limitations of the Project
When considering the CPG in clinical practice, there are few facilitators and
barriers that must be addressed. The main strength of the CPG is the use of the
WHOQOL-BREF questionnaire to measure QOL in patients diagnosed with anxiety
and/or depression. Prior to developing the CPG, permission was granted from the WHO
to utilize the WHOQOL-BREF questionnaire. The WHOQOL-BREF questionnaire is
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evidence-based and has been supported in prior studies to be of a valid and reliable tool
to measure QOL in various settings, hence, its use in the CPG. Limitations of the CPG
was centered on the body of evidence used to support the recommendations.
First, in the study by Oliveira et al. (2016), some of the study participants were
inpatients in both short-term and long-term residential programs having more limited
daily activities which may affected the results, specifically, regarding the environment
domain of the WHOQOL-BREF (Oliveira et al., 2016). Additionally, since the study
used a cross-sectional approach, findings should be required to be repeated applying a
longitudinal research design to strengthen understanding the dimensionality of the
WHOQOL-BREF in psychiatric samples as well as the analytical capacity of its domains
(Oliveira et al., 2016). Though this evidence supported the effective use of the
WHOQOL-BREF questionnaire, it did not focus specifically on anxiety and/or
depression disorders in outpatient setting but variety of psychiatric samples in both
inpatient and outpatient settings. The broad sample size could be a limitation in this
literature review.
Second, in the study by Tüzün et al. (2015) researchers focused on other chronic
diseases in addition to mental health disorders to assessed QOL using the WHOQOLBREF. Depression and anxiety were not particularly the only mental health disorders
considered in the study. This is a limitation because the results of the QOL assessment
could have been influenced by other chronic illnesses of the participants.
Third, in the study by Dzevlan et al. (2016), researchers used the Quality of Life
and Satisfaction Questionnaire (Q-LES-Q-SF) to assess life enjoyment and satisfaction in
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patients taking antidepressant therapy (Dzevlan et al., 2019). The use of the Q-LES-QLSF could be considered a limitation when considering this evidence to support the CPG
because a different QOL measurement besides the WHOQOL-BREF was used to assess
QOL perceptions. However, bear in mind that this evidence was used to provide an
overview of specific timeframes of when QOL measurements can be done in the clinical
setting after starting antidepressant therapy for depression and/or anxiety disorders.
Last, in the evidence by Deane and Fain (2016), it was generally geared toward
nursing education but offered valuable information to promote therapeutic nurse-patient
relationship using Peplau’s theory. When considering the CPG, be advised that though
Peplau’s interpersonal relations theory has been widely used in patients with mental
health disorders, a recent evidence discussing the application of the three phases of the
theory (orientation, working and termination) in patients with depression and anxiety in
the primary care setting, specifically, could not be found. The application of the evidence
by Deane and Fain (2016) in the CPG provided a framework to support the interventions
outlined in the CPG that clinicians can employ when delivering the WHOQOL-BREF
questionnaire to measure QOL in the target population.
The CPG recommended a specific tool that can be used to measure QOL in
patients diagnosed with anxiety and/or depression in the primary care setting. It also
offered recommendations on how and when to utilize the tool (WHOQOL-BREF
questionnaire) in clinical practice to improve patient outcomes. Implications for applying
the recommendations have been considered such as providing clinicians with a better
understanding of patients’ perceptions of QOL in relation to their anxiety and/or
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depression, and ability for clinicians to measure QOL in order to better manage their
treatment plans. An expert review of the CPG has been performed to add quality to its
application in clinical practice to influence care delivery.
Summary
High-quality, evidence-informed CPG provides a way to bridge the gap between
policy, best practice, local contexts, and the choices of patients (Kredo et al., 2016). For
decades, clinical guidelines have been supported as a vital component of quality medical
practice (Kredo et al., 2016). The objective of the CPG was to help clinicians make
informed clinical decisions regarding the proper care of patients with anxiety and/or
depression to enhance patient care using evidence-based recommendations. Health
benefits, side effects, and risks were considered in the formulation of the
recommendations outlined in the CPG. To accomplish this, the body of evidence
supporting the recommendations of the CPG underwent critical appraisal to ensure
relevance, transparency, enhanced health benefits and examination of any potential side
effects or risks. Upon review of the body of evidence supporting this CPG, no side
effects, or risks were found. The project team served as a n integral part of the guideline
by offering their expertise and evaluating the completed guideline using the AGREE II
instrument. Application of the recommendations made in the guideline can positively
influence care delivery and promote overall optimal mental health outcome in the
targeted population.
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Section 5: Dissemination Plan
Introduction
After observing that a local primary care clinic lacked QOL measurement for
patients with anxiety and/or depression, poor outcomes in various domains of their QOL
became evident that affected their overall health. Based on this observation, it was
necessary to develop a CPG with recommendations on the best way to measure QOL to
holistically care for the patients. I conducted a literature review to evaluate the impact of
anxiety and/or depression on patients’ QOL, which revealed that depression and anxiety
negatively impact an individual’s QOL.
Evidence gathered from the literature to support the CPG illustrated that the
WHOQOL-BREF questionnaire was a reliable and valid tool to evaluate QOL in patients.
Previous research analyzed for relevance to the CPG found that the use of WHOQOLBREF questionnaire in patients with psychiatric disorders such as anxiety and/or
depression helped to assess their QOL. Upon review of the literature and analyzing the
results, I developed a CPG recommending the application of the WHOQOL-BREF tool
as the best method to measure QOL in the target population.
The target users for the CPG would be suitable in disseminating the project in a
larger aspect of the nursing profession and healthcare. The target users for the CPG are
healthcare clinicians working with patients with anxiety and/or depression in the
outpatient setting (i.e., primary care). These clinicians can use the CPG to assess the
target populations’ QOL to generate effective treatments ideal to addressing patients’
mental health needs. Other intended users such as registered nurses, licensed practical
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nurses, and nursing assistants caring for individuals with anxiety and/or depression can
also apply the CPG as part of the data collection process during patient encounters to
evaluate the impact of their conditions on their QOL. Based on the information gathered
from the CPG, nurses can collaborate with advanced practice nurses or physicians to
either initiate or amend specific treatments to address patients’ needs. After the
publication of the CPG, its dissemination would target healthcare providers including
advanced practice nurses, nurses, primary care physicians, psychologists, psychiatrists,
and other mental health personnel caring for patients diagnosed with anxiety and/or
depression.
Because the problem was initially identified at a local primary care clinic, once
the guideline is available for use, healthcare organizations can first introduce it to either
their medical officer or hierarchy of the organization for review and then disseminate it
equally to their clinicians to use to guide their clinical practices. There was no
implementation for the CPG at a specific organization; however, recommendations on the
best approach to measure QOL in the target population were outlined step-by-step in the
guideline. Because there was no implementation of the CPG at a selected institution,
target users can employ the recommendations in their individual practices, settings, or
organizations to enhance care delivery and attain optimal mental health outcomes.
Analysis to Self
The development of the CPG and my overall project compelled me to consider
my role as a practitioner, scholar, and project manager. My expertise in working with
patients with anxiety and/or depression revealed the importance of QOL in these patients.
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My observation of the lack of proper assessment of patients’ QOL in the primary care
setting inspired me to take a deeper look into the correlation between anxiety and/or
depression and QOL. Additionally, as a practitioner, I considered how I could evaluate
this important concept to holistically care for my patients suffering from anxiety and/or
depression.
In my role as a practitioner working with patients diagnosed with anxiety and/or
depression in the primary care setting, I have had ample opportunities to assess the
impact of these two mental health disorders on patients’ QOL. I have treated patients
with anxiety and/or depression using either psychotherapy or pharmacological approach
and assessed the impact of these treatments using the standardized PHQ9 and GAD7
without evaluating in depth their QOL due to lack of a standardized measurement tool.
However, the completion of the DNP project helped me to identify a reliable tool as the
best approach to assess QOL.
The development of the CPG helped me to act and grow as a scholar. The
findings noted through the literature search process for the project provided in-depth
insights regarding the health question considered for the project. I was able to apply
knowledge gained through my education to search and obtain reliable resources to
influence the development of the guideline.
Leadership skills gained throughout my nursing career helped me to act as a
project manager in developing the CPG. I was able to effectively collaborate with my
project team who helped to review the project and to solicit feedback regarding the
recommendations made in the CPG. As a project manager, I took a leadership role in
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ensuring that the objectives of my project were met. I also guided my expert panel by
explaining how to use the AGREE II instrument to review the guideline. This project
experience significantly enhanced my leadership skills as a practitioner and provided me
experience as a scholar and project manager. These essential skills will assist me as a
clinician and help me to meet my professional goals in the future.
Successful completion of this project was possible due to the support obtained
from the project team, family, and close friends. Considering that this was my biggest
educational achievement, I was anxious about potential setbacks that could have
impacted the overall project. Because the expert panel had various backgrounds, I was
concerned about how to collaborate with them to solicit feedback on the CPG.
Additionally, the waiting period to receive feedback from the project team was a
challenge. However, providing constant communication such as sending periodic
reminders through e-mails, text messages and phone calls was helpful to bridge the gap
between the expert panel and myself. Additionally, I explained the intent of the guideline
to give the expert panel an overview of the overall project. Completing this project has
enhanced my confidence as scholar practitioner and a leader. The skills obtained through
this project will guide me to meet my professional goals as I embark on becoming a
change agent in my community and the nursing profession.
Summary
The aim of this project was to develop a CPG recommending the best way to
measure QOL in patients with anxiety and/or depression in the outpatient setting. The
developed guideline illuminates a step by step approach to measure QOL life using the
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WHOQOL-BREF tool. As previously stated, the CPG offers healthcare clinicians
comprehensive information on measuring QOL, which can influence treatment plans to
improve the lives of patients suffering from anxiety and/or depression in the outpatient
setting.
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Appendix A: Evidence Matrix
Reference

Purpose/ Question

Design

Adams, L. Y.
(2017)

How Peplau’s theory
of interpersonal
relations contributed
to clinical,
conceptual, and
empirical
Knowledge in
psychiatric nursing
and the nursing
profession
AGREE II Manual

Academic paper

AGREE (2017)

Sample

Results

None

Utilization of
Peplau’s
interpersonal
theory in
nursing practice

Peplau’s theory
contributes to nursing
knowledge
and the discipline of
nursing specifically
psychiatric/
mental health nursing

None

Manual on using
the AGREE II

User’s manual on how
to use the AGREEE II

Nine thousand
seven hundred
seventy-six
documents were
retrieved. 98
guidelines that
mentioned
the use of
GRADE
methodology
was discovered.

Literature search
in databases
such as
developer’s
websites, health
ministries,
repositories and
grey literature.
Region focused
was Latin
America and the
Caribbean

Findings indicate a slow
and increasing
integration of the
GRADE methodology
in the region. GRADE
methods could help to
enhance the quality and
validity of
recommendations

Convenience
sampling of 43
patients with
depression and
43 patients with
schizophrenia
recruited from
an outpatient
clinic and
psychiatric ward

Patients'
psychiatric
symptoms,
subjective QOL,
self-efficacy,
perceived social
support, and
coping style
were explored
with the use a 4page self-report
surveys
Participants
were
interviewed with
the use of topic
guided questions
from Sept–Nov
2010

Results indicated that
psychosocial variables,
such as social support
and self-efficacy, need
to be measured in their
impact on QOL for
patients with depression
and schizophrenia

GRADE score:
Very low

Manual

Intervention

GRADE score:
Very low

Cabrera et al.
(2019)

Choo et al.
(2019)

Connell et al.
(2014)

Building an evidence
map to show the
regional GRADE
impact in developing
clinical practice
guidelines and
differentiate the
results with current
needs.

A systematic
literature search

Study was intended
to investigate the
prediction of Quality
of Life (QOL) in
Asian patients with a
major mental
disorder such as
depression or
schizophrenia in
Singapore

Use of selfreported surveys

Identify the domains
of QOL that are
important to people
with mental health
problems to evaluate
the content validity
of these generic
measures (i.e. EQ-

Qualitative
study of face-toface semistructured
interviews with
existing users of
mental health
services

GRADE score:
moderate

GRADE score:
Very low

12 men and 7
women with
range of mental
health problems
and levels of
severity such as
schizophrenia,
schizo-affective

Findings indicated that
generic preferencebased measures (EQ-5D
and SF-6D) do not
consist of many aspects
of QOL valued by those
with mental health
problems
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5DSF-6D)
GRADE score:
Very low

Deane & Fain
(2016)

Dzevlan et al.
(2019)

Evans et al.
(2017)

Examined Peplau’s
interpersonal
relations theory as a
framework to help
nursing students to
comprehend holistic
communication skills
in their encounters
with older adults
Evaluate
improvement of
QOL, tolerability of
therapy and patients
diagnosed with
anxiety and/or
depression adherence
with antidepressants.

Research article

Examined a novel,
nontraditional
counselling treatment
model for pregnant
women at risk for
Antepartum
depression (APD)

Complementary
mixed-methods
design. Peplau’s
theory of
interpersonal
relations was
used as a
framework to
guide the study

disorder,
personality
disorder, posttraumatic stress
disorder
(PTSD), mild to
severe
depression,
anxiety,
agoraphobia,
eating disorder,
and anger
Not Applicable

GRADE score:
Very low

A clinical,
multicenter,
prospective,
cohort study

682 patients of
both sexes
observed over 9
months period

GRADE score:
Low

GRADE score:
Very low

sample size of
24 nurse–
women dyads
(458
interactions,
generating 293
pages of phone
log data)

Application of
Peplau’s theory
to enhance
holistic
communication
among nursing
students and
older adults
Patients were
divided into 3
groups, MOS
(Medical
Outcomes
Study) sleep
scale and QLES-Q-SF
(Quality of Life
Enjoyment and
Satisfaction
QuestionnaireShort Form)
scale were
utilized to
evaluate QOL
Nurses provided
consistent,
therapeutic
interactions
during
pregnancy and
addressed many
of the barriers to
adequate care
when women
are depressed.
Researchers
examined the
interactions that
occurred
between nurses
and the
participants
using Peplau’s
Interpersonal
Relations theory

Utilized as a framework
in nursing education to
structure classrooms,
post-conferences, and
skills laboratory
presentations on
components of
delivering holistic care
and communication
Sleep quality was
significantly improved
in all patients regardless
of the antidepressants
used. The overall
pleasure and
satisfaction with life
also improved.

The phases of Peplau’s
theory of interpersonal
relations were evident
in the interactions
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Feder et al.
(2015)

GonzálezBlanch et al.
(2018)

Hagerty et al.
(2017)

Assessed selfreported QOL among
individuals residing
in areas with varying
levels of wind turbine
noise exposure

Questionnaire

Randomly
selected
participants
aged 18–79 (606
males, 632
females) living
between 0.25
and 11.22 km
from wind
turbines

Use of World
Health
Organization
QOL-BREF
(WHOQOLBREF)
questionnaire to
evaluate of
participants
QOL

Examine the
relationships between
four various QOL
domains and the most
prevalent clinical
symptoms (i.e.,
depression, anxiety,
and somatization),
while regulating for
sociodemographic
variables

Randomized
controlled trial
GRADE score:
High

1241
participants
from 28 primary
care centers in
Spain

The study was a
secondary data
analysis of one
hospital
system’s
HCAHPS
survey results
using
confirmatory
factor analyses
(CFAs)

The sample
consisted of
15,814 patients,
≥18 years of
age, who had at
least one
overnight
hospital stay and
received an
HCAHPS
survey in 2013

Participants
were evaluated
using the Patient
Health
Questionnaire
(PHQ)-9 to
evaluate
depression;
Generalized
Anxiety
Disorder Scale
(GAD)-7 for
anxiety; PHQ15 for
somatization;
and WHOQOLBREF to
evaluate four
QOL domains
(i.e. physical
health,
psychological
health, social
relationships,
and
environment)
HCAHPS
surveys were
administered in
48 hours to 6
weeks after
hospital
discharge to a
random sample
of adult patients
with a range of
health
conditions

To report the results
of a confirmatory
factor analysis
performed to
compare the factor
structure of
Consumer
Assessment of
Healthcare Providers
and Systems–
Hospital (HCAHPS)
data using both the
Institute of Medicine
conceptual model and
Peplau’s middlerange theory of
interpersonal
relations in nursing

GRADE score:
Very low

GRADE score:
Very low

Participants who were
exposed to increased
WTN levels did not rate
their QOL or
Satisfaction with Health
considerably worse than
those who were
exposed to decreased
WTN levels, nor did
they report having
substantially worse
outcomes in terms of
factors that comprise
the 4 domains of the
WHOQOL-BREF
Depression was the
strongest predictor for
all domains of QOL.
Clinical symptoms
described more of the
difference in QOL than
sociodemographic
factors such as age, sex,
level of education,
marital status, work
status, and income

A two-factor model
based on Peplau’s
theory performed
sufficiently well,
whereas a three-factor
model also based on
Peplau’s theory fit them
excellently and
provided an appropriate
alternative factor
structure for the data.
Results support the use
of Peplau’s theory to
show nursing’s vast
contribution to the
experiences of
hospitalized patients
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Hofmann et al.
(2017)

Hohls et al.
(2019)

Examine the impact
of Cognitivebehavioral therapy
(CBT) and selective
serotonin reuptake
inhibitors (SSRIs) for
depression on QOL

Synthesize evidence
from longitudinal
studies on the
relationship between
anxiety, depression
and QOL in a
systematic review.

A search of
PubMed and
PsycINFO
databases for
articles
published from
1994 to present
was conducted
on 20 June 2014
and updated 17
October 2016.
GRADE score:
Very low
Systematic
review protocol
of evidence
from
longitudinal
studies

CBT (24 studies
examining
1969 patients) or
SSRI treatment
(13 studies
examining 4286
patients)

Meta-analysis of
prior studies

CBT and SSRIs for
depression were both
related to moderate
improvements in QOL,
but are probably
caused by various
mechanisms

Projected to
review sample
of 100
titles/abstracts

Search on
electronic
databases from
relevant fields of
research
(PubMed,
PsycINFO,
PSYNDEX,
EconLit, NHS
EED)
Researchers
administered the
SF-12 (a healthrelated qualityof-life
(HRQOL)
questionnaire
consisting of
twelve questions
that measure
eight health
domains to
assess physical
and mental
health) annually
for three years

No information
provided

Not applicable

Not applicable

Increasing awareness to
measure QOL in
individuals with mental
disorders

Not Applicable

Discussed how
the Donabedian
framework can
promote quality
of mental health
care

Offered several
recommendations for
implementing quality
measurement as an
ultimate tool for
enhancing quality of
mental health care

GRADE score:
Very low
Huo et al.
(2018)

Katschnig
(2006)

Kilbourne et al.
(2018)

Assessed the
reliability of SF-12
among individuals
with behavioral or
serious mental health
conditions enrolled in
the Texas
STAR+PLUS
Medicaid Managed
Care program who
also participated in
the Wellness
Incentive and
Navigation (WIN)
project.

Explored the tension
among the common
sense meaning of
QOL and the efforts
to pin it down as a
measurable concept
Presented a
framework for
encouraging quality
measurement to
improve quality of
mental health care

Three-year
longitudinal
randomized
pragmatic
clinical trial
funded by the
Center for
Medicare &
Medicaid
Services’
Medicaid
Incentives for
the Prevention
of Chronic
Conditions
portfolio
GRADE score:
High
Article

Sample of 1587
participants with
either a
combination of
physical and
behavioral
conditions or
serious mental
illness

GRADE score:
Very low

Article
GRADE score:
Very low

Study results
demonstrated good
reliability of SF-12 to
evaluate HRQOL in
individuals with
behavioral conditions or
serious mental illness
that may qualify for
supplemental security
income
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Kong et al.
(2015)

Kornhaber et
al. (2016)

Kredo et al.
(2016)

Kroenke et al.
(2016)

Movsisyan et
al. (2018).

Study aimed to
assess the quality of
evidence of
systematic
reviews/metaanalyses (SRs/Mas)
for acute kidney
injury (AKI) using
the GRADE system
Identified strategies
that improve
therapeutic
interpersonal
relationships in the
acute care setting

Systematic
search in the
electronic
databases
for SRs/Mas

Aimed to provide a
guide illustrating
common standards,
methods and systems
utilized in current
international CPG
activities and the
many activities to
generate and
communicate them
Examined the
reliability and
validity of the Patient
Health Questionnaire
Anxiety-Depression
Scale (PHQ-ADS) –
which merged the
PHQ-9 and GAD-7
scales – as a
composite measure of
depression and
anxiety
Identified and
examined existing
systems for rating the
quality of a body
of evidence on the
effectiveness of
health and social
interventions.

Article

Not applicable

Use of GRADE
system to rate
the quality of
evidence

GRADE was revealed
as a scientific and
effective method to
evaluate the quality of
evidence

10 studies
included in the
integrative
review

Systematic
search was
conducted of
PubMed,
Cumulative
Index to Nursing
and Allied
Health
Literature, and
PsycINFO

Not applicable

No specific
intervention
applied

It was discovered that
“therapeutic listening,”
“responding to patient
emotions and unmet
needs”, and “patient
centeredness” were the
main characteristics of
strategies for improving
therapeutic
interpersonal
relationships
Concluded that CPG
methods in the next
decade will be in
updating, adopting,
contextualizing, and/or
adapting, and
implementing

Data from 896
patients enrolled
in 2 primary
care-based trials
of chronic pain
and oncology
practice

Based trial of
depression and
pain were
examined

PHQ-ADS showed high
internal reliability

Identified 17
systems for
evaluating the
quality of a
body of
evidence on
intervention
effectiveness
across health
and social policy

Used a
multicomponent
search strategy
to search for
full‐length
reports of
systems for
rating the
quality of a
body of
evidence from
1995 onward

Researchers found little
reporting of rigorous
procedures in the
development and
dissemination of
evidence rating systems

GRADE score:
Low
Integrative
review
GRADE score:
Very low

GRADE score:
Very low

Clinical Trial
GRADE score:
Low

Research article
GRADE score:
Very low
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Muntingh et al.
(2016)

Examined the
efficacy of
collaborative care for
anxiety disorders in
primary care adult
patients compared to
care as usual

Systematic
review and
meta-analysis to
summarize
results from
randomized
controlled trials
GRADE score:
Moderate
Statistic data
Grade: Very low

National
Institute of
Mental Health
(2019)

Prevalence of mental
illness in the United
States

Oliveira et al.
(2016)

Examined the
psychometric
properties of the
WHOQOL-BREF by
means of testing its
dimensionality,
construct validity,
predictive validity,
and reliability in a
Portuguese
psychiatric sample of
inpatients and
outpatients

Cross-sectional

Analyzed the
differences and
similarities of the
concepts of comfort,
well-being, and
quality of life (QOL)

Concept
analysis method

Focused on the social
changes in the 21st
century and the effect
this has had and will
have on mental
health, particularly in
India.

Article

Pinto et al.
(2017)

Prasad et al.
(2016)

GRADE score:
Low

GRADE score:
Very low

GRADE score:
Very low

3073 studies
found; seven
studies were
included with a
total of 2105
participants.

Systematic
search for
studies with
collaborative
care
interventions

All studies except
study four reported a
substantially greater
impact of the
collaborative care
intervention compared
to care as usual

Not applicable

Not applicable

Statistical data on
mental illnesses in
United States

Sample
comprised of
403 participants

Researchers
administered the
WHOQOLBREF
questionnaire
focusing on four
domains
measuring:
psychological
health, physical
health, social
relationships,
and
environment,
plus two items
representing the
general QOL
Evaluation of
concept analysis
research on
PubMed, Cinahl
(full text) and
Scielo

Support for the
multidimensionality of
the WHOQOL-BREF
which showed it to be
appropriate for the
evaluation of QOL in
psychiatric inpatients
and outpatients.
WHOQOL-BREF
revealed as a valuable
tool to be integrated as
part of the routine
clinical evaluation,
monitoring and an
essential indicator of
treatment outcome as
well as research
Comfort appears to be
more associated with
symptom relief and/or
decreased imbalances or
discomfort, inner peace,
security, and efficient
communication. The
concept of well-being is
reliant on psychospiritual basis, related to
happiness and an
“internal energy.” QOL
seems to be a broader
concept, linked with life
improvement, dignity
and attaining
independence and
personal goals
Concluded that
advancement in
technology as part of
social change can
improve awareness,
help-seeking behaviors,
and access to mental

98 results were
identified but
only 18 studies
were included in
this review.
Three studies
related to the
concept of
comfort, three
studies the
concept of wellbeing, and 12
studies the
concept of QOL

Not applicable

Not applicable
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health care

Sivertsen et al.
(2015)

Slade et al.
(2006)

Tüzün et al.
(2015)

WHO (1996)

Reviewed the
literature on the
relationship between
depression
and QOL in older
persons

Systematic
review

To assess the efficacy
of
standardized outcome
assessment

Randomized
Control Trial

Analyzed the effect
of chronic disease on
the quality of life
(QOL) and how QOL
alters with
comorbidity and
socioeconomic status
in people who attend
primary health care
centers.
WHOQOL-BREF
manual

Face-to-face
questionnaire
with people
greater than or
equal to 18
years.

GRADE score:
Moderate

953 studies were
revealed; 74
studies were
included in the
review; of these,
52 were crosssectional studies
and 22 were
longitudinal
studies
160 adult mental
health patients
and paired staff

GRADE score:
High

2560
participants
comprised who
contacted six
primary health
care centers

GRADE score:
Very low
Manual/Questio
nnaire
GRADE score:
High

Not applicable

A systematic,
computerized
search in the
MEDLINE,
PubMed,
PsychINFO,
EMBASE and
CINAHL
databases
Intervention
group (n-101)
(a) received a
completed
monthly
questionnaire to
evaluate their
needs, QOL,
severity of their
mental health
problems and
their therapeutic
alliance; (b)
received 3
monthly
feedback. The
control group
(n=59) received
usual treatment
Use of the
World Health
Organization
Quality of Life
Questionnaire
Abbreviated
Version
(WHOQOLBREF)
questionnaire
Selfadministered or
interviewerassisted
instrument

Found a substantial
connection between
severity of depression
and poorer QOL in
older persons, and the
relationship was found
to be steady over time,
regardless of which
assessment instruments
for QOL were applied.
Routine use of outcome
measures did not
enhance subjective
outcomes, but study
showed reduced
psychiatric inpatient
admissions.

Mental disorders among
the disorders with the
most negative effect on
the QOL.

QOL is scored based on
scores from each
domain
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World
Federation for
Mental Health
(2012)

Depression being a
global public health
concern

Article
GRADE score:
Very low

Not applicable

Not applicable

Concludes with
educating
ourselves regarding
depression and support
those who
are suffering from this
mental disorder
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Purpose
The incidence of mental health conditions has resulted in high rates of disabilities
nationally and globally. Approximately 25% of adults living in the United States has
some degree of mental health disorder (Huo et al., 2018). Patients suffering from mental
health problems are known to have higher prevalence of other chronic conditions such as
heart diseases, diabetes, obesity, asthma, epilepsy, as well as cancer (Huo et al., 2018).
Precisely, anxiety and depression are among the most prevalent types of mental health
disorders across different ages of the lifespan (Hohls et al., 2019). Research has showed
that individuals diagnosed with other medical conditions concurrently with a mental
health disorder have a significantly higher impairment in their QOL (Huo et al., 2018).
Quality of life refers to the person’s welfare, contentment in life, physical health,
perceptions of social relationships, financial status, and functioning in their activities of
daily living and work (Hofmann et al., 2017). QOL is influenced by the person’s beliefs,
morals, health, and experiences gained in life. Based on the literature review conducted to
identify the best QOL measurement tool, a standardized QOL measurement tool could
not be found. From a local context, a gap in practice was observed at a primary care
organization. Clinicians who worked in this local primary care setting lacked appropriate
measurement tool to evaluate QOL in patients diagnosed with anxiety and/or depression.
As a result of this, poor outcomes in various domains of patients’ QOL became evident
within the patient population.
In comparison to other mental disorders, patients with depression have reported
reduced QOL (Choo et al., 2019). Anxiety disorders can also have a negative effect on an
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individual’s QOL and are associated with major healthcare productivity and financial
burden (Muntingh et al., 2016). Given that patients with anxiety and depression have a
higher risk of negative quality of life, it was vital to find out the best approach to measure
QOL in patients with anxiety and/or depression.
Objective
In practice, guidelines are formulated to offer clinicians the evidence and
knowledge required to provide efficient, high-quality, and safe care to populations with
certain clinical situations. The objective of this clinical practice guideline was to help
clinicians measure QOL in patients suffering from anxiety and/or depression to make
informed decisions regarding their care and enhance outcomes based on evidence-based
recommendations. The CPG can serve as a guide for clinicians to evaluate patients’
perceptions of quality of life based on various domains such as physical health, social
relationships, psychological health, and environment in order to make necessary
adjustments in their care to improve outcomes as well as their quality of life. The
intended health benefit for applying the CPG is improved perception of quality of life in
patients with anxiety and/or depression seeking care in the outpatient setting.
Health Question
The health question that guided the development of the CPG was:
PFQ: How should QOL be measured in patients with anxiety and/or depression in
the outpatient setting?
Target Population
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The intended population that the recommendations can be applied are adult
patients, all genders, ages 18 years and older with anxiety and/or depression seeking care
in an outpatient setting.
Stakeholder Involvement
The clinical practice guideline development incorporated the works of highquality evidence and various reliable tools from other professional groups. These tools
consisted of the WHOQOL-BREF questionnaire, GRADE methodology and the AGREE
II instrument. Since the CPG aimed at recommending the best way to measure QOL in
patients with anxiety and/or depression, there were no direct subjective views or
preferences obtained from the target population.
Target Users
The target users for the CPG are healthcare clinicians working in the outpatient
setting such as primary care. Healthcare clinicians include but not limited to advanced
practice nurses, nurse practitioners, nurses, physicians, psychologists, psychiatrists, and
other mental health professionals. These clinicians can utilize the CPG to assess the target
populations’ QOL to generate effective treatments ideal to addressing patients’ mental
health needs.
Recommendations
The following recommendations have been reviewed by an expert panel and
graded utilizing the GRADE methodology. The level of evidence used to support each
recommendation was graded and assigned a rating of very low, low, moderate, or high as
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indicated on the GRADE methodology. The guideline recommended the application of
the WHOQOL-BREF tool to answer the health question:
PFQ: How should QOL be measured in patients with anxiety and/or depression in
the outpatient setting?
The domains of the recommendations addressed the following (1) what to use to measure
QOL (2) when to measure QOL (3) how to use the WHOQOL-BREF questionnaire and
(4) how to apply Peplau’s theory with the WHOQOL-BREF tool. The evidence
supporting each recommendation was illustrated at the end of each section of the
recommendations. The guideline and recommendations were reviewed by an external
expert panel against the AGREE II instrument for its contents.
What to Use to Measure QOL. Though numerous studies on QOL have resulted
in various tools that clinicians can use in practice, the most suitable approach to measure
QOL is based on individualized care and the patient’s overall condition as well as the
intended use of the assessment.
Use the WHOQOL-BREF questionnaire to measure QOL in patients with anxiety
and/or depression receiving care in the outpatient setting (GRADE score: Low). The
WHOQOL-BREF questionnaire is a tool used to assess QOL perceptions and must be
used without modifications. It has been widely used in numerous researches in its original
form and has been found to be a valid and reliable tool to measure QOL. With the
WHOQOL-BREF questionnaire, clinicians can obtain baseline scores in an array of
areas, as well as observing patterns or changes in QOL over the course of interventions
(WHO, 1996).
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Evidence supporting recommendation. Based on a literature review of a study
that tested the psychometric properties of the WHOQOL-BREF by investigating its
construct validity, predictive validity as well as reliability in a psychiatric study sample,
findings supported the multidimensionality of the WHOQOL-BREF which showed
suitable properties for assessing Qol in psychiatric inpatients and outpatients (Oliveira et
al., 2016). The WHOQOL-BREF showed that it was a valuable instrument to be
integrated as part of the regular clinical evaluation, monitoring and an essential indicator
of treatment outcome as well as research (Oliveira et al., 2016).
When to Measure QOL. The actual time that clinicians would need to evaluate
QOL depends on other elements such as the time of initial diagnosis, pharmacotherapy
initiation, and/or referral to psychotherapy as well as during the titration of medication.
1. Measure QOL routinely (GRADE score: High)
a. Measure baseline QOL at the following times (GRADE score: Low)
i.

At the time of initial diagnosis (such as Generalized Anxiety
Disorder Assessment (GAD7) score of four and above or
Patient Health Questionnaire (PHQ9) score of four and above)

ii.

Initial prescription of pharmacotherapy

iii.

Referral to psychotherapy

2. Obtain subsequent QOL assessments during follow up appointments to
evaluate patients’ symptoms and response to treatments (GRADE score:
Low). The WHOQOL-BREF tool guidelines do not suggest specific time to
repeat QOL assessment, however, it mentions that various time frames can be
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used and suggests changing the time scale as appropriate (WHO, 1996).
Timeframes for follow up QOL assessments is based on current evidence
supporting when clinicians should follow up with patients after the diagnoses
of anxiety and/or depression and started pharmacotherapy treatment.
3. Re-evaluate QOL scores routinely such as at the three weeks follow up visit
after starting new treatments (i.e., antidepressants and/or psychotherapy) and
respectively while receiving treatment at seven weeks follow up appointment,
eleven weeks, 24 weeks, and 36 weeks after baseline (GRADE score: High).
Evidence supporting recommendation. Upon review of the literature, a study by
Slade, McCrone, Kuipers, Leese, Cahill, Parabiaghi, Priebe, and Thornicroft (2006)
conducted a randomized control study to assess the efficacy of standardized outcome
assessment in 160 adult mental health patients and paired staff. The researchers stressed
the feasibility of the implementation of a carefully developed technique to routinely
evaluate outcomes in mental health services (Slade et al., 2006). The study demonstrated
that a meticulously developed and implemented method to regularly collect and use
outcome information has been shown to decrease admissions and save money in mental
health patients (Slade et al., 2006).
Kilbourne et al. (2018) suggested mental health outcomes ought to be evaluated
more routinely and must become an aspect of the whole culture of the treatment setting as
well as the health care system. Routine outcome measurements have been associated with
enhancements in service delivery and low hospital re-admission rates, but intermittent
outcome measurement lacked to enhance quality (Kilbourne et al., 2018). Furthermore,
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regular outcome measurement provided back to the clinician and utilized to influence
treatment decisions with the patient, led to better QOL (Kilbourne et al., 2018).
Dzevlan et al. (2019) assessed patients’ QOL after starting antidepressants during
a nine-month period. QOL measurements were assessed at baseline and five additional
times. The first QOL assessment was performed three weeks after the baseline, the
second assessment was completed seven weeks after the baseline, the third assessment
was performed at 11 weeks after the baseline, the fourth assessment was completed at 24
weeks after the baseline and the fifth assessment was performed at 36 weeks after the
baseline (Dzevlan et al., 2019). Clinicians using this CPG can mirror these timeframes for
follow up visits after the initiation of antidepressants to assess QOL by administering the
WHOQOL-BREF questionnaire.
How to Use the WHOQOL-BREF Questionnaire. Proper administration of the
WHOQOL-BREF questionnaire is key to retrieving relevant responses from patients
(Appendix D).
1. Provide the self-administered WHOQOL-BREF questionnaire to competent
patients to complete the assessment (WHO, 1996) (GRADE score: Very low).
2. Offer an interviewer-assisted format of the WHOQOL-BREF questionnaire to
patients who are unable to complete the self-administered questionnaire
(WHO, 1996) (GRADE score: Very low).
3. Provide clear instructions to patients on the proper way to complete the selfadministered WHOQOL-BREF questionnaire (WHO, 1996) (GRADE score:
Very low).
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4. Read the interviewer-assisted questionnaire out aloud to patients (WHO,
1996) (GRADE score: Very low).
5. Review responses under each QOL domain with the patient as indicated on
the WHOQOL-BREF and clarify any misunderstanding or add further details
accordingly (WHO, 1996) (GRADE score: Very low).
6. Discard the assessment if greater than 20% of information is lacking from the
WHOQOL-BREF questionnaire (WHO, 1996) (GRADE score: Very low).
7. Calculate the mean score of items in each domain, which is utilized to
establish the domain score and then multiply by four to be comparable to the
scores obtained on the WHOQOL-100 (WHO, 1996) (GRADE score: Very
low).
Evidence supporting recommendations. Tüzün et al. (2015) evaluated the effect
of chronic disease on QOL and how QOL alters with comorbidity and socioeconomic
status in individuals seeking care at primary health care centers. The level of QOL was
established by using the WHOQOL-BREF. The scale was converted to Turkish, and the
study of reliability and validity were completed (Tüzün et al., 2015). In harmony with the
directions prepared for the users of WHOQOL-BREF, the researchers calculated raw
scores for each domain (Tüzün et al., 2015). Results showed that mental disorders (such
as depression, anxiety, and somatization) were part of the chronic diseases with the most
negative impact on the QOL. Mental disorders were the only diseases with a huge effect
across all domains on the WHOQOL-BREF in the linear regression models (Tüzün et al.,
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2015). Specifically, the results also indicated that depression could lead to a decline in
several QOL scale domains such as the physical domains (Tüzün et al., 2015).
How to Apply Peplau’s Theory with the WHOQOL-BREF tool. Applying
Peplau’s theory of Interpersonal Relations in every patient encounter promotes and helps
to maintain an effective relationship with patients. Clinicians can apply the interventions
below during their interactions with patients such as when administering the WHOQOLBREF questionnaire.
1. Address patients by their names and maintain privacy and safety during the
meet and greet phase (GRADE score: Very low).
2. Show respect and courtesy towards patients to achieve useful information
about them as individuals (GRADE score: Very low).
a. Apply this when asking questions on the WHOQOL-BREF and providing
instructions on the self-administered questionnaire
3. Establish rapport with patients to enhance the clinician-patient relationship
(GRADE score: Very low).
4. Use professional knowledge and holistic attitude to help the patient with their
health concerns by asking questions and allow sufficient time for responses
(GRADE score: Very low). This can be accomplished by performing an
assessment (i.e., WHOQOL-BREF questionnaire) which can be used to
educate and influence the patient’s treatment plan.
5. Interact with patients kindly and be mindful of the use of body language and
gestures (GRADE score: Very low).
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Evidence supporting interventions. Peplau’s interpersonal relations theory was
used to support nursing students to comprehend holistic communication skills in their
encounters with older adults (Deane & Fain, 2016). Peplau’s theory offers nursing a
valuable set of three interconnecting and oftentimes intersecting working phases for
nurses’ interaction with patients during the nurse–patient relationship (Deane & Fain,
2016). In the orientation phase, the nurse greets the patient by addressing them by their
name and with professional title (Deane & Fain, 2016). As the orientation phase
continues, the patient persists to inquire and respond to questions with the nurse, hoping
to feel secure during their interactions (Deane & Fain, 2016).
The nurse utilizes professional knowledge and skills alongside a holistic attitude
to assist the patient solve his or her health concerns (Deane & Fain, 2016). Nurses must
be mindful of their body language and the gestures they demonstrate during nurse–patient
interaction and strive from maximum verbal and minimal nonverbal communication
during patient interactions (Deane & Fain, 2016). In the working phase, which is known
as the assessment period, nurses need to show respect and maintain privacy to promote
trust, depict a professional and respectful rapport with the patient (Deane & Fain, 2016).
Procedure Guideline Update
The clinical practice guideline should be evaluated and revised yearly by an
organizational review panel utilizing existing high-quality research, and
recommendations that are evidence-based. Since the WHOQOL-BREF questionnaire was
the main component of this CPG and has been in its originality since its publication in
1996, updates to the guideline may not affect the tool. Any future changes that may occur
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with the WHOQOL-BREF questionnaire would necessitate an update to the clinical
practice guideline. In cases whereby updates are needed, partial updates could be made
and the National Institute for Health and Care Excellence (NICE) recommendations on
partial updates of guidelines can be used as guidance to make the necessary changes.
Conflict of Interest
There were no funding body that could have influenced the content of this
guideline. There was no related conflict of interest to report for the clinical practice
guideline. Permission to use the WHOQOL-BREF was obtained from the WHO
(Appendix E).
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Appendix C: The WHOQOL-BREF Questionnaire
Questions Under Each Domain
Overall quality of life and general health
How would you rate your quality of life?
How satisfied are you with your health?
Domain 1: Physical health
To what extent do you feel that physical pain prevents you from doing
what you need to do?
How much do you need any medical treatment to function in your daily
life?
Do you have enough energy for everyday life?
How well are you able to get around?
How satisfied are you with your sleep?
How satisfied are you with your ability to perform your daily living
activities?
How satisfied are you with your capacity for work?
Domain 2: Psychological
How much do you enjoy life?
To what extent do you feel your life to be meaningful?
How well are you able to concentrate?
Are you able to accept your bodily appearance?
How satisfied are you with yourself?
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How often do you have negative feelings such as blue mood, despair,
anxiety, depression?
Domain 3: Social relationships
How satisfied are you with your personal relationships?
How satisfied are you with your sex life?
How satisfied are with the support you get from your friends?
Domain 4: Environment
How safe do you feel in your daily life?
How healthy is your physical environment?
Have you enough money to meet your needs?
How available to you is the information that you need in your daily-to-day
life?
To what extent do you have the opportunity for leisure activities?
How satisfied are you with the condition of your living place?
How satisfied are you with your access to health services?
How satisfied are you with your transport?
(WHO, 1996)
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Appendix D: The WHOQOL-BREF Questionnaire: Response Options

1. How would you rate your quality of life?
1 Very poor 2 Poor 3 Neither poor nor good 4 Good 5 Very good
2. How satisfied are you with your health?
1 Very dissatisfied, 2 Dissatisfied, 3 Neither satisfied nor dissatisfied, 4
Satisfied, 5 Very satisfied
The following questions ask about how much you have experienced certain things in the
last
four weeks:
3. To what extent do you feel that physical pain prevents you from doing what
you need to do?
5 Not at all , 4 A little, 3 A moderate amount, 2 Very much, 1 An extreme
amount
4. How much do you need any medical treatment to function in your daily life?
5 Not at all , 4 A little, 3 A moderate amount, 2 Very much, 1 An extreme
amount
5. How much do you enjoy life?
1 Not at all , 2 A little, 3 A moderate amount, 4 Very much, 5 An extreme
amount
6. To what extent do you feel your life to be meaningful?
1 Not at all , 2 A little, 3 A moderate amount, 4 Very much , 5 Extremely
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7. How well are you able to concentrate?
1

Not at all , 2 A little, 3 A moderate amount, 4 Very much , 5 Extremely

8.

How safe do you feel in your daily life?
1

9.

Not at all, 2 A little, 3 A moderate amount, 4 Very much , 5 Extremely

How healthy is your physical environment?
1

Not at all, 2 A little, 3 A moderate amount, 4 Very much , 5 Extremely

The following questions ask about how completely you experience or were able to do
certain
things in the last four weeks:
10. Do you have enough energy for everyday life?
1 Not at all, 2 A little, 3 Moderately, 4 Mostly, 5 Completely
11. Are you able to accept your bodily appearance?
1 Not at all, 2 A little, 3 Moderately, 4 Mostly, 5 Completely
12. Have you enough money to meet your needs?
1 Not at all, 2 A little, 3 Moderately, 4 Mostly, 5 Completely
13. How available to you is the information that you need in your day-to-day life?
1 Not at all, 2 A little, 3 Moderately, 4 Mostly, 5 Completely
14. To what extent do you have the opportunity for leisure activities?
1 Not at all, 2 A little, 3 Moderately, 4 Mostly, 5 Completely
15. How well are you able to get around?
1 Very poor, 2 Poor, 3 Neither poor nor good, 4 Good, 5 Very good
16. How satisfied are you with your sleep?
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1 Very dissatisfied, 2 Dissatisfied, 3 Neither satisfied nor dissatisfied, 4
Satisfied, 5 Very satisfied
17. How satisfied are you with your ability to perform your daily living activities?
1 Very dissatisfied, 2 Dissatisfied, 3 Neither satisfied nor dissatisfied, 4
Satisfied, 5 Very satisfied
18. How satisfied are you with your capacity for work?
1 Very dissatisfied, 2 Dissatisfied, 3 Neither satisfied nor dissatisfied, 4
Satisfied, 5 Very satisfied
19. How satisfied are you with yourself?
1 Very dissatisfied, 2 Dissatisfied, 3 Neither satisfied nor dissatisfied, 4
Satisfied, 5 Very satisfied
20. How satisfied are you with your personal relationships?
1 Very dissatisfied, 2 Dissatisfied, 3 Neither satisfied nor dissatisfied, 4
Satisfied, 5 Very satisfied
21. How satisfied are you with your sex life?
1 Very dissatisfied, 2 Dissatisfied, 3 Neither satisfied nor dissatisfied, 4
Satisfied, 5 Very satisfied
22. How satisfied are you with the support you get from your friends?
1 Very dissatisfied, 2 Dissatisfied, 3 Neither satisfied nor dissatisfied, 4
Satisfied, 5 Very satisfied
23. How satisfied are you with the conditions of your living place?
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1 Very dissatisfied, 2 Dissatisfied, 3 Neither satisfied nor dissatisfied, 4
Satisfied, 5 Very satisfied
24. How satisfied are you with your access to health services?
1 Very dissatisfied, 2 Dissatisfied, 3 Neither satisfied nor dissatisfied, 4
Satisfied, 5 Very satisfied
25. How satisfied are you with your transport?
1 Very dissatisfied, 2 Dissatisfied, 3 Neither satisfied nor dissatisfied, 4
Satisfied, 5 Very satisfied
The following question refers to how often you have felt or experienced certain things in
the
last four weeks.
26. How often do you have negative feelings such as blue mood, despair, anxiety,
depression?
5 Never, 4 Seldom, 3 Quite often, 2 Very often, 1 Always
(WHO, 1996)
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Appendix E: World Health Organization Copyright Authorization for WHOQOL-BREF
(Permission #: 311574)
Dear Mary,
Thank you for submitting the online form and for your interest in World Health
Organization (WHO) Quality of Life materials. On behalf of WHO, we are pleased to
authorize your request to reproduce, reprint and/or translate WHOQOL tools and
instruments as detailed in the form below, subject to the terms and conditions of the nonexclusive license below. WHOQOL-100 and WHOQOL-BREF available language
versions and the translation guidelines are available for download at:
http://terrance.who.int/mediacentre/data/WHOQOL/
For more information and other WHOQOL materials, visit WHOQOL website. We thank
you for your interest in WHO published materials.

Kind regards,
Dolores Campanario
WHO Permissions Team
WORLD HEALTH ORGANIZATION
Non-exclusive licence to use selected WHO published materials
You submitted a request, through WHO’s online platform, for permission to reprint and
reproduce certain WHO copyrighted material (the “Licensed Materials”). This is a legal
agreement (the “Agreement”) between you and WHO, granting you a license to use the
Licensed Materials subject to the terms and conditions herein.
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Read this Agreement in its entirety before using the Licensed Materials.
By using the Licensed Materials, you enter into, and agree to be bound by, this
Agreement. This license is granted only for original materials belonging to WHO. If any
part of the WHO published materials you wish to reproduce are credited by WHO to a
source other than WHO, those materials are not covered by this Agreement and are not
part of the Licensed Materials. You are responsible for determining if this is the case, and
if so, you are responsible for obtaining any necessary permission from the source of
those third-party materials prior to their use.
If you enter into this Agreement on behalf of an organization, by using the Licensed
Materials you confirm (represent and warrant) that you are authorized by your
organization to enter into this Agreement on the organization’s behalf. In such a case, the
terms “you” and “your” in this Agreement refer to, and this Agreement applies to, the
organization.
WHO grants this license to you based on the representations and warranties you made in
the license request you submitted through WHO’s online platform. If any of those
representations and/or warranties are or become false or inaccurate, this license
agreement shall automatically terminate with immediate effect, without prejudice to any
other remedies which WHO may have.
If you have questions regarding this Agreement, please contact permissions@who.int
1. License. Subject to the terms and Conditions of this Agreement, WHO grants to
you a worldwide, royalty free, non-transferable, non-sublicensable, non-exclusive
licence to use, reproduce, publish, and display the Licensed Materials in the
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manner and using the media indicated in the Permissions Request Form you
submitted to WHO (the “Licensed Use”). This licence is limited to the current
edition of your work. Future editions or a different use of the Licensed Materials
will require additional permission from WHO. If your request includes translation
into different languages, then non-exclusive permission is hereby granted to
translate the Licensed Materials into the languages indicated in accordance to
article 4 of this Agreement.
2. Licensed Use. The Licensed Material shall be used in the manner and using the
media indicated in the Permissions Request Form you submitted to WHO (the
“Licensed Use”). The Licensed Materials are intended for use in clinical research,
drug trials, conducting assessments and studies, for use by clinicians in clinical
contexts and for any academic and educational use. The Licensed Materials
should not be sold individually or incorporated into products for sale, without
written authorization from WHO.
3. Retained Rights. Copyright in the Licensed Materials remains vested in WHO,
and WHO retains all rights not specifically granted under this Agreement.
4. Translation of the Licensed Materials. The Translation shall be faithful to the
original English text and rendered into good literary and scientific language. The
Translation should be done in accordance with the translation guidance
methodology provided by WHO and available for download
at http://terrance.who.int/mediacentre/data/WHOQOL/WHOQOL100/Guidelines/. The PDF of the translation should be provided to WHO with
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permission 1) to make the PDF available on WHO web site and institutional
repository and 2) to use, amend, adapt, reproduce, publish and distribute the PDF
or its part(s) for any purpose whatsoever.
5. Mandatory Acknowledgement. In every instance of the Licensed Use, you must
make suitable acknowledgement of WHO as follows, either as a footnote or in a
reference, as follows. In addition, If the Licensed Materials originate from
the WHO web site, you must also include the URL reference and the date
accessed.
“Reproduced with permission from (TITLE), Geneva, World Health Organization
(WHO), (Year of publication), (URL, accessed (insert date). WHO does not endorse any
specific companies, products or services.”
Translations and adaptations of the Licensed Materials should be attributed as follows:
“Translated into (insert language) from (TITLE), Geneva, World Health Organization
(WHO), (Year of publication), (URL, accessed (insert date). WHO is not responsible for
the content or accuracy of this translation/adaptation. In the event of any inconsistency
between the English and the insert language translation, the original English version
shall be the binding and authentic version.”
6. Product Delivery: The Licensed Materials can be downloaded online
at http://terrance.who.int/mediacentre/data/WHOQOL/
7. Altering or Modifying the Licensed Materials. As part of the Licensed Use, you
may minimally alter the Licensed Materials to match the format or style of your
publication. Any other alteration or modification of the Licensed Materials
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(including abbreviations, additions, or deletions) may be made only with the prior
written authorization of WHO. You may not add company or product branding to
the Licensed Materials.
8. Appropriate and Prohibited Uses. You must use the Licensed Materials in a
factual and appropriate context. You may not use the Licensed Materials in
association with any product marketing, promotional, or commercial activities,
including, without limitation, in advertisements, product brochures, companysponsored web sites, annual reports, or other non-educational publications or
distributions. Any additional use requires written permission from WHO.
9. No WHO endorsement. You shall not state or imply that WHO endorses or is
affiliated with your publication or the Licensed Use, or that WHO endorses any
entity, organization, company, or product.
10. No use of the WHO logo. In no case shall you use the WHO name or emblem, or
any abbreviation thereof.
11. No Warranties by WHO. All reasonable precautions have been taken by WHO to
verify the information contained in the Licensed Materials. However, WHO
provides the Licensed Materials to you without warranty of any kind, either
expressed or implied, and you are entirely responsible for your use of the
Licensed Materials. In no event shall WHO be liable for damages arising from
your use of the Licensed Materials.
12. Your Indemnification of WHO. You agree to indemnify WHO for, and hold
WHO harmless against, any claim for damages, losses, and/or any costs,
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including attorneys' fees, arising in any manner whatsoever from your use of the
Licensed Materials or for your breach of any of the terms of this Agreement.
13. Termination. The license and the rights granted under this Agreement shall
terminate automatically upon any breach by you of the terms of this Agreement.
Further, WHO may terminate this license at any time with immediate effect for
any reason by written notice to you.
14. Entire Agreement, Amendment. This Agreement is the entire agreement between
you and WHO with respect to its subject matter. WHO is not bound by any
additional terms that may appear in any communication from you. This
Agreement may only be amended by mutual written agreement of you and WHO.
15. Headings. Paragraph headings in this Agreement are for reference only.
16. Dispute resolution. Any dispute relating to the interpretation or application of this
Agreement shall, unless amicably settled, be subject to conciliation. In the event
of failure of the latter, the dispute shall be settled by arbitration. The arbitration
shall be conducted in accordance with the modalities to be agreed upon by the
parties or, in the absence of agreement, with the rules of arbitration of the
International Chamber of Commerce. The parties shall accept the arbitral award
as final.
17. Privileges and immunities. Nothing in or relating to this Agreement shall be
deemed a waiver of any of the privileges and immunities enjoyed by WHO under
national or international law and/or as submitting WHO to any national court
jurisdiction.
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***
WHOQOL-100 and WHOQOL-BREF language versions and translation guidelines are
available at: http://terrance.who.int/mediacentre/data/WHOQOL/
For more information and other WHOQOL materials, visit WHOQOL website
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